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SUMMARY 
This report describes the results of a collaborative study of an HPLC method for the antibiotic 
virginiamycin in four feeds. The collaborative study forms part of the EU-project "Development and 
Validation of HPLC-methods for the official control of Coccidiostats and Antibiotics used as Feed 
Additives (CANFAS-SMT4-CT98-2216). 
The principle of the method is as follows: Virginiamycin Ml is extracted from wetted feedingstuffs 
with ethyl acetate in an ultrasonic bath. A part of the extract is purified with tandem Solid Phase 
Extraction (SPE) using Silica and OASIS HLB cartridges. The eluate of the solid phase extraction is 
evaporated under nitrogen and the residue is dissolved in HPLC eluent. From this fraction a part is 
injected on a liquid chromatography system with a 'reversed phase' column. Isocratic elution is 
used and UV detection at 235 nm is applied. 
The samples which were prepared for the collaborative study were a broiler feed and a bull feed 
with declared virginiamycin contents of 2 and 5 mgAg resp., 1 blank broiler feed and 1 blank 
piglet feed. The samples were sent to the participants as blind duplicates. The participants were 
asked to do duplicate determinations per sample. 
Results were reported by 12 laboratories. Statistical evaluation was performed according to ISO 
5725. From the results it can be concluded that the repeatability and the reproducibility of the 
method are unsatisfactory. The measurement uncertainty of quantitative results is much larger 
than generally considered as acceptable. Thus, the applicability of the method is restricted to 
semi-quantitative use, which means that any quantitative result should only be reported together 
with a clear statement of the measurement uncertainty. 
From the results it can be concluded that the method is suitable as a screening method to 
discriminate between positive samples containing 2 mgAg virginiamycin (or more) and negative 
samples. From the information obtained in this collaborative study it is not possible to deduce if 
the method is also suited to discriminate between samples containing 1 mg/kg (the target value 
from the Project Plan) and negative samples. 
The results of the collaborative study were evaluated in a meeting attended by the participants. 
The panel agreed with the conclusions stated above about repeatability, reproducibility and 
applicability of the method. 
The method will not be recommended for adoption as an official method. It was agreed that no 
further work will be done in the CANFAS-project. New work will be started in SIMBAG-FEED, taking 
into account the results of the CANFAS-project. 
1 INTRODUCTION 
Within the framework of the EU-project "Development and Validation of HPLC-methods for the 
official control of Coccidiostats and Antibiotics used as Feed Additives (CANFAS-SMT4-CT98-
2216), a method was developed for virginiamycin. Virginiamycin is an antibiotic which was 
registered for use in feeds for poultry, piglets, pigs, calves, laying hens, cattle for fattening and 
sows with contents ranging from 5 - 50 mgAg. Since July 1999 the use of virginiamycin as a 
feed additive is banned in the EU. In order to allow adequate control of possible illegal use, the 
objective was to develop an HPLC method with UV-detection that allows the determination of 
virginiamycin at sub-additive levels, viz. depending on the type of feed down to 1 - 4 mgAg. 
The method was developed and validated by RIKILT, Wageningen, The Netherlands (see report 
C.A.J. Hajee, Final report on method development and validation for the determination of 
virginiamycin in animal feeds, 08-11-1999). The method is based on the detection of virginiamycin 
Ml as the marker compound and UV detection at 230 nm. It proved to be necessary to apply a 
tandem clean-up with Sep-Pak silica gel and OASIS HLB cartridges. The overall LOQ-level was 
estimated at 2.44 mgAg- Recoveries at the LOQ level ranged from 38 to 67 %, repeatabilities 
from 7 to 26 % and within-lab reproducibilities from 13-27 %. The applicability of the method is 
restricted to semi-quantitative, screening purposes only. 
Subsequently, the method was subjected to between-lab validation by the National Veterinary 
Institute (NVI), Uppsala, Sweden (see report A. Stepinska, February 2000) and Danish Plant 
Directorate (DPD), Lyngby, Denmark (see report A. Ploger, 07-02-2000). The results of DPD were 
similar to the results of RIKILT with repeatabilities from 5 - 33 % and recoveries from 22 - 90 %. 
The results of NVI were better: higher and less fluctuating recoveries (64 - 89 %), better 
repeatabilities (1 - 5 %). Based on the results of NVI, new chromatographic conditions were 
adopted which make it possible to lower the LOQ to 1 mgAg (see Second Annual Report 
CANFAS, J. de Jong, 12-08-2000). 
Prior to the collaborative study, a kick-off meeting was organised (Brussels, 13-14/6/2000). In 
this meeting it was decided to organise a small-scale collaborative study with 2 positive feed 
samples (broiler and bull feed) and 2 blank samples. An important issue for the collaborative study 
would be to show the possibility to discriminate between positive and negative samples. 
Participating laboratories were given the opportunity to familiarise themselves with the method, 
using feed samples with stated contents of virginiamycin. Also prior to the production of the 
materials for the collaborative study, separate batches of the materials were produced for 
homogeneity and stability testing. The between-sample homogeneity was satisfactory but the 
within-sample homogeneity of the bull feed was too high. Interpretation of the results of stability 
testing was difficult due to the variability already observed during homogeneity testing. Best 
results were obtained with storage at room temperature. For bull feed and broiler feed less than 
50 % breakdown was observed in 4 months. 
The samples that were prepared for the collaborative study were a broiler feed and a bull feed 
with declared virginiamycin contents of 2 and 5 mgAg respectively and 2 blank feeds. The feed 
samples were sent to the participants as blind duplicates. Before these samples were shipped, 
the between- and within-sample homogeneity of the feed samples containing virginiamycin was 
checked with satisfactory results (see par. 3.1.2). 
Together with the samples, a letter with instructions, reporting forms, etc. was sent to the 
participants (see Appendix 1). 
This report describes the results of the collaborative study. 
2 PARTICIPANTS 
The following laboratories/persons participated in the collaborative study. 
- Danish Plant Directorate, Lyngby, Denmark; A. Plager, A. Kraemer-Peterson 
- Departement voor Kwaliteit van Dierlijke Producten, Melle, Belgium; H. de Ruyck, H. de Ridder, 
L. Batjoens, P. de Neve 
- INETI/DTIA, Lisbon, Portugal; I. Felgueiras, N. Simôes 
- Istituto Superiore di Sanita, Lab. Med. Veterinaria, Roma, Italy; G. Brambilla, C. Cartoni, M. 
Fiori. 
- Istituto Zooprofilattico Sperimentale délia Lombardia e dellémilia Ronagna, Reparto Chimico, 
Brescia, Italy; E. Faggionato, A. Baiguera. 
- Istituto Zooprofillatjco Sperimentale délie regioni Lazio e Toscana, Roma, Italy; A. Ubaldi, A. di 
Lullo. 
- Laboratório Nacional de Sanidad y Produccion Animal - M.A.P.A., Santa Fe, Spain; R. Checa-
Moreno, A. Ariza-Avidad. 
- Laboratory of the Government Chemist, Teddington, United Kingdom; G. Merson, J. Cowles, P. 
Ponnampalavanar. 
- LNIV, Lisbon, Portugal; J.M. Nunes da Costa, M.B. Casqueira. 
- National Veterinary Institute, Uppsala, Sweden; E. Nordkvist, A. Stepinska 
- Rijksontledingslaboratorium, Tervuren, Belgium; K. Haustraete, A. Fontaine, M. Bral, R. van 
San. 
- RIKILT, Wageningen, The Netherlands; C.A.J. Hajee, R. Regnat 
- Staatliche Landwirtschaftliche Unersuchungs- und Forschungsanstalt (LUFA), Augustenberg, 
Germany; A. Thalmann, K. Wagner 
- State Laboratory Dublin, Ireland; P. Shearan, A. Murphy 
3 MATERIALS 
3.1 Samples for collaborative study 
3.1.1 Sample composition 
The specifications of the samples, which were produced for the collaborative study, are given in 
Table 1. 
Table 1: Specifications of the samples 
Type of feed 
Broiler feed 
Bull feed 
Declared 
content 
2 
5 
Units 
mg/kg 
mgAg 
Subcontractor 
IPC - Dier, Barneveld 
(NL) 
IPC - Dier, Barneveld 
(NL) 
Date of 
production 
06/09/2000 
06/09/2000 
The complete composition of the feeds is given in Appendix 2 (in Dutch). 
The main composition of the two feeds is given in Table 2. 
Table 2: Main composition of the two feeds 
""""""""""^--^^^ Product 
Ingredient ~~~"~^-~—^^^ 
Crude protein (%) 
Crude fat (%) 
Starch (%) 
Crude fibre (%) 
Crude ash (%) 
Moisture (%) 
Virginiamycin (mgAg) 
Broiler 
17,0 
7,9 
40,8 
3,5 
5,5 
11,4 
2 
Bull 
18,1 
5,2 
1,3 
9,4 
not known 
11,3 
5 
The composition of the feeds was equal to the composition of the products that were produced 
by IPC-Dier in October 1999 for homogeneity and stability testing (see Report on homogeneity 
and stability studies of samples for the collaborative studies for virginiamycin, U.M. Driessen 
and J. de Jong, RIKILT, Wageningen, NL, June 2000). 
The feed products have been prepared in a quantity of 500 kg each. To achieve a maximum 
degree of homogeneity halfway through the production 54 kg of broiler feed and 72 kg of bull 
feed are withdrawn from the stream for subsampling activities and put into sacks of 18 kg. After 
discarding the top layer (ca. 2 kg) about 40 - 50 subsamples of approx. 250 grams have been 
taken (manual distribution with a shovel) from each of these sacks. The subsamples were stored 
in double paper sacks and were numbered in the order in which they were filled. 
All subsamples have been stored at room temperature (ca. 20 °C). 
Next to the above mentioned samples which contained virginiamycin, two blind blank feeds were 
sent to the participants as well as a blank feed labelled "blank feed for virginiamycin recovery 
purposes" (see Appendix 1). The blind blank feeds concerned a broiler feed with 20 mg 
nicarbazin per kg and a piglet feed with 2,5 mg carbadox per kg/7,5 mg olaquindox per kg. The 
20 ppm nicarbazin containing broiler feed has also been applied as recovery blank. These feeds 
were analysed at RIKILT prior to the collaborative studies. The blank broiler feed contained no 
detectable amounts of virginiamycin or interfering substances. In the blank piglet feed a signal of 
approx. 0,02 mgAg was measured at the retention time of virginiamycin (while this signal is 
much smaller than the limit of detection (estimated at 1 mgAg) exact quantification is not 
possible). 
3.1.2 Sample homogeneity 
The homogeneity of the samples was studied by RIKILT by random selection of 10 subsamples, 
applying the HPLC-method developed in CANFAS (see Annex 1 of Appendix 1). 
The results of the homogeneity determinations of the individual feeds are attached (see 
Appendix 3). Table 3 gives a summary of these results. 
Table 3: Results of homogeneity tests for virginiamycin in broiler feeds 
^ \ . Results 
Product ^ \ 
Broiler feed 
Bull feed 
Declared 
content 
(mgAg) 
2 
5 
Measured 
content 
(mgAg) 
0,94 
2,17 
Homogeneity results 
Between sample CV (%) 
35,8 
26,5 
Within sample CV (%) 
37,4 
21,6 
The mean values for the measured contents are only ca. 45 % of the declared contents. This 
observation is similar to previous findings (see Report on homogeneity and stability studies of 
samples for the collaborative studies for virginiamycin, J.J.M. Driessen and J. de Jong, RIKILT, 
Wageningen, NL, June 2000) and is mainly caused by the relatively low recovery of the method. 
According to the Project Plan the CVs for homogeneity should not exceed 2 times the CV's for 
repeatability (CVhom < 2 CVr). Based on previous results of within-lab validation (see Second 
Annual Report CANFAS, J. de Jong, 12-10-2000) the maximum limit for CVhom was set to 60 %. 
All between- and within-sample CVs fulfil this requirement. Thus, it is concluded that the samples 
are sufficiently homogeneous. 
3.1.3 Sample logistics 
The feed samples were sent as blind duplicates. The codes are given in Appendix 4. The 
samples were sent to the participants by courier service on 2 October 2000 together with a 
letter with instructions (Appendix 1). During transport no special precautions were taken with 
regards to the temperature of the samples. 
3.2 Reference standard 
The reference standard was supplied by Dr. A. Roger, Danish Plant Directorate, Lyngby (DK). 
According to the specifications (see Appendix 5), the reference standard (Lot Nr. 98162-QCS) has 
a microbiological potency of 225 % (2250 ^g/mg). 
The expiration date of the reference standard was January 2000. For this reason the content and 
identity was checked with LC-UV and LC-MS respectively. The content was compared by RIKILT 
with two similar reference standards also originating from Pfizer with an expiration date of January 
2003. The results showed that there is no significant difference in the content of virginiamycin Ml 
between the three standards The identity of virginiamycin Ml was confirmed by means of LC-MS3 
(see report of C.A.J. Hajee, RIKILT, included in Appendix 5). 
4 METHODS 
4.1 Method of analysis 
The method of analysis is included as annex 1 to Appendix 1. The participants were instructed 
that this method has to be used without any modifications. 
4.1.1 HPLC-conditions 
Various types of HPLC-columns were used (the column which was recommended in the method 
is a Lichrospher C18 or Hypersil BDS C18, 250 mm x 4,6 mm with a particle size of 5 urn). 
The mobile phase described in the method is water/acetonitrile/formic acid 100% (600:400:3 
v/v/vA Two laboratories used a different mobile phase. 
The HPLC conditions (Column and mobile phase) used by the participants are shown in Table 4. 
Table 4: HPLC-conditions 
Partner 
11 
15 
21 
22 
25 
26 
28 
29 
31 
32 
37 
38 
Column 
Lichrospher CI8, 250 mm x 4,6 mm 
As described in the method. 
LC 18 supelcosil 25 cm x 4,6 mm + 
supelguard LCB 
Hyperlil ODS BDS CI8, 250 x 4,6; 5 
Mm 
As described in the method. 
Spherisorb ODS-2 
As described in the method. 
Waters Sperisorb ODS-2 
5 fj.m; 4,6 x 250 mm 
As described in the method. 
Waters Symmetry, CI8, 5 urn, 
4,6mm x 250 mm 
Hypersil BDS C18; 25 cm x 4,6 mm, 5 
urn 
Hypersil ODS C-18, 250 x 4,6 mm; 5 
urn 
Mobile phase 
As described in the method 
As described in the method. 
As described in the method. 
As described in the method. 
Acetonitrile:water:formic acid = 
450:550:3 (v/v/v) 
As described in the method. 
As described in the method. 
As described in the method. 
As described in the method. 
As described in the method. 
As described in the method. 
Water:acetonitrile:Acetic acid = 
650:350:3 (v/v/v) 
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4.2 Method for statistical evaluation 
Statistical evaluation was performed according to ISO 5725 Part 2: Basic method for the 
determination of repeatability and reproducibility of a standard measurement method (First 
edition, 1994-12-15). 
The scrutinity of results for consistency and outliers was checked by 
a) Graphical consistency techniques: Mandel's h plot for between-laboratory variability, Mandel's 
k plot for within-laboratory variability 
b) Numerical outlier techniques: Cochran's test of the within-laboratory variability, Grubbs' test 
(single and double) for between-laboratory variability 
Whenever necessary and appropriate, laboratories which showed consistently high within-cell 
variation and/or extreme cell means across many levels and/or Cochran or Grubbs' outliers were 
contacted to try to ascertain the cause of the discrepant behaviour. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility of the method. 
The Horwitz equation gives a prediction for the relative standard deviation (RSD) under 
reproducibility condition, based on the empirical formula: RSD_R,% = 2 [ i a 5 1 0 l o g ( c ) I , where c 
refers to the decimal level. The HORRAT ratios are given in Table 5. The HORRAT ratios should be 
lower than 2 (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). 
H 
5 RESULTS 
For each participant the reported results for the samples, the completed questionnaire and 
representative chromatograms are annexed in Appendix 6. 
5.1 Statistical evaluation 
The results reported by the participants are given in Table 9. Figure 1 demonstrates the Mandel h 
and k plots of these results. The values for the statistical parameters (mean, relative standard 
deviations for repeatability and reproducibility), taking into account all the results of all 
participants, are also given in Table 9. 
Lab 31 is a Cochran outlier for one of the 2 mgAg samples. 
Lab 37 is a Grubbs' upper outlier at both levels and a Cochran outlier for one of the 5 mg/kg 
samples. Lab 37 was contacted to ascertain that the reported values were correct. The lab 
responded that no irregularities could be traced and that, in accordance with the instructions, the 
results were not corrected for recovery. For the 5 mgAg sample it should be stressed that the 
reported values (6,05 - 8,04 mgAg) are closer to the dosed content than the values reported by 
most of the other laboratories. The same applies to the duplicate values for one of the 2 mgAg 
samples (2,28 and 2,42 mgAg)- For this reason it is not straightforward that the results of lab 37 
should be removed from the statistical evaluation. Other arguments to retain the results of lab 37 
are the results of tasks 1 - 3 of the project (low and fluctuating recoveries, high rsdr's, inexplicable 
results during the stability studies; see Second Annual Report CANFAS, J. de Jong, 12-08-2000). 
This point has been discussed during the evaluation meeting (see chapter 6). 
The values for the statistical parameters after removal of all the results of lab 37 and the results 
of one of the 2 mgAg samples of lab 31 (Cochran outlier) are given in Table 10. Figure 2 
demonstrates the Mandel h and k plots of these results. 
The rsdr values in Table 9 and 10 have been calculated from the duplicate results of individual 
samples, which means that at each level 24 pairs of duplicates have been used in the statistical 
analysis. The reason is that in a number of cases the differences between the mean values of the 
2 duplicate samples of the same level are larger than the differences for the duplicate analyses in 
the same sample. See for example lab 15, 5 mgAg sample: difference between the means of the 
2 samples is 1,75 - 0,34 = 1,41 mgAg; difference between the duplicate analysis in one sample 
is 0,03 mgAg for the first and 0,14 mgAg for the second sample. The relatively large 
differences obtained in some laboratories between the 2 samples of the same level may be 
attributed to inhomogeneity between samples. In order to estimate the effects of sample 
heterogeneity from the differences between the two samples analyzed in each laboratory also a 
more elaborate analysis was made in addition to the standard analysis of ISO 5725-2. In this 
analysis along the lines of ISO 5725-3 three variance components were estimated: laboratory 
differences, sample differences and repeatability differences. Variance components were 
estimated using residual maximum likelihood (REML) as implemented in the statistical package 
Genstat release 4.2, both on the complete data set, and on the set after discarding outliers. 
12 
The results from the REML variance component analyses, expressed relatively to the sample 
means, are shown in Tables 5 and 6. 
Table 5: Variance components (relative to mean) calculated from all data 
Laboratory 
Samples within 
laboratory 
Replicates 
2mgAg 
1,828 
2,038 
0,0295 
5mg/kg 
0,8206 
0,0478 
0,0372 
Pooled 
1,324 
1,043 
0,0334 
Table 6: Variance components (relative to mean) calculated after discarding outliers 
Laboratory 
Samples within 
laboratory 
Replicates 
2mgAg 
0,2163 
0,0822 
0,0215 
5mgAg 
0,3696 
0,1012 
0,0289 
Pooled 
0,2930 
0,0921 
0,0253 
From these variance components the performance characteristics can be calculated as shown in 
Tables 7 and 8. 
Table 7: Relative standard deviations calculated from all data 
rsdr (%) 
rsdR (excluding sample 
heterogeneity) (%) 
rsdR (no correction for 
heterogeneity) (%) 
2mgAg 
17,2 
136,3 
197,4 
5mgAg 
19,3 
92,6 
95,2 
Pooled 
18,3 
116,5 
154,9 
Table 8: Relative standard deviations calculated after discarding outliers 
rsdr (%) 
rsdR (excluding sample 
heterogeneity) (%) 
rsdR (no correction for 
heterogeneity) (%) 
2mgAg 
14,7 
48,8 
56,6 
5mgAg 
17,0 
63,1 
70,7 
Pooled 
15,9 
56,4 
64,1 
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These analyses show that: 
- Pooling of the rsd's over the two concentration levels (2 and 5 mgAg) is a reasonable option 
after discarding of the outliers; 
- The contribution of sample heterogeneity to the total variance is sizeable (0,09), and cannot 
be ignored (in comparison to the other variance components 0,29 and 0,025); 
- The largest contribution to the total variance (after discarding outliers) is due to between-
laboratory differences (0,29). 
Consequently the rsdR values in this analysis, when corrected for sample heterogeneity, are 
smaller than in the simple ISO 5725-2 analysis (e.g. 56 % in comparison to 64 % for the pooled 
data after discarding outliers). However, they are still too large in consideration of the HORRAT 
criterion. 
According to the Project Plan, the rsdr-values should be < 10 %. For both samples the values are 
higher. On the other hand the values are similar to the values obtained in tasks 1 and 2 of the 
project (see par. 1 ; these values were obtained with spiked samples) and even better than the 
values obtained for within-sample homogeneity (see par. 3.1.2, Table 3). 
Thus it can be concluded that, with regards to the repeatability, the results of the collaborative 
study are in line with the results of within- and between-lab validation of the method. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). The HORRAT ratios 
are given in Tables 11 (all results) and 12 (without the Grubbs' and Cochran outliers). The HORRAT 
ratios should be lower than 2. Although improved results are obtained after removal of the 
Grubbs' outliers, for both samples the HORRAT ratios (3,20 and 4,67) are still too high. 
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Table 9: Virginiamycin results for the positive feeds and statistical evaluation with all results 
Sample 
Lab 
11 
15 
21 
22 
25 
26 
28 
29 
31 
32 
37 
38 
Resull 
VIRG 2 mgAg 
0,27 
0,68 
0,40 
0,55 
0,21 
1,30 
0,70 
0,82 
0,63 
0,11 
7,88Guo 
0,52 
0,37 
0,69 
0,50 
0,53 
0,21 
1,10 
0,43 
0,71 
0,61 
0,10 
lost sample 
0,54 
VIRG 2 m gAg 
0,63 
0,57 
0,40 
0,58 
0,22 
1,30 
0,68 
0,22 
l,33C o 
0,12 
2,28Guo 
0,79 
0,68 
0,40 
0,60 
0,54 
0,22 
1,10 
0,64 
0,17 
0,58Co 
0,12 
2,42Guo 
0,78 
(mgAg) 
VIRG 5 mgAg 
3,32 
0,35 
1,40 
1,24 
0,51 
3,00 
1,81 
0,83 
2,28 
0,16 
8,04Co/Guo 
1,45 
2,87 
0,32 
1,40 
1,31 
0,58 
3,90 
0,91 
1,14 
2,66 
0,51 
6,05Co/Guo 
1,61 
VIRG 5 m gAg 
3,83 
1,82 
2,40 
1,42 
0,73 
2,70 
1,51 
0,91 
2,91 
0,19 
799GUO 
0 
4,30 
1,68 
2,20 
1,71 
0,70 
3,00 
1,73 
1,04 
2,24 
0,55 
7 I 2 6 G U O 
0 
number of labs 
m (mgAg) 
rsdr(%) 
rsdR (%) 
12 
0,79 
17,1 
148 
12 
2,09 
19,3 
93,3 
Key to symbols: 
result00 = Cochran outlier 
result0"0 = Grubb's upper outlier 
15 
Table 10: Virginiamycin results for the positive feeds and statistical evaluation after discarding 
outliers 
Sample 
Lab 
11 
15 
21 
22 
25 
26 
28 
29 
31 
32 
37 
38 
Result (mg/kg) 
VIRG 2 mgAg 
0,27 
0,68 
0,40 
0,55 
0,21 
1,30 
0,70 
0,82 
0,63 
0,11 
7,88s"0 
0,52 
0,37 
0,69 
0,50 
0,53 
0,21 
1,10 
0,43 
0,71 
0,61 
0,10 
lost sample 
0,54 
VIRG 2 mgAg 
0,63 
0,57 
0,40 
0,58 
0,22 
1,30 
0,68 
0,22 
1,33e" 
0,12 
2,283uo 
0,79 
0,68 
0,40 
0,60 
0,54 
0,22 
1,10 
0,64 
0,17 
0,58=° 
0,12 
2,42*» 
0,78 
VIRG 5 mgAg 
3,32 
0,35 
1,40 
1,24 
0,51 
3,00 
1,81 
0,83 
2,28 
0,16 
8,04Co/GM 
1,45 
2,87 
0,32 
1,40 
1,31 
0,58 
3,90 
0,91 
1,14 
2,66 
0,51 
Qß&oXw 
1,61 
VIRG 5 mgAg 
3,83 
1,82 
2,40 
1,42 
0,73 
2,70 
1,51 
0,91 
2,91 
0,19 
79gSuo 
0 
4,30 
1,68 
2,20 
1,71 
0,70 
3,00 
1,73 
1,04 
2,24 
0,55 
7,2&uo 
0 
number of labs 
m (mgAg) 
rsdr(%) 
rsdR (%) 
11 
0,54 
14,7 
56,3 
11 
1,62 
17,0 
69,4 
Remark 1: Italic printed results are not taken into account in the statistical evaluation! 
Key to symbols: 
result00 = Cochran outlier 
resultGu0= Grubb's upper outlier 
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Figure 1: Mandel h and k plots of the results reported by the participants taking into account all 
the results of all participants 
Lab code XXI refers to the first set of a 2 mgAg and a 5 mgAg sample of lab XX, 
lab code XX2 refers to the second set 
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Figure 2: Mandel h and k plots of the results reported by the participants after discarding 
Outliers. 
Lab code XXI refers to the first set of a 2 mgAg and a 5 mg/kg sample of lab XX, 
lab code XX2 refers to the second set 
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Table 11: Horrat ratios of the virginiamycin collaborative study (all results) 
Mean (mg/kg) 
0,79 
2,09 
Predicted rsdR 
(%) 
16,58 
14,32 
Established rsdR 
(%) 
148 
93,3 
Horrat1 
8,92 
6,51 
Conclusion 
Reproducibility NOT OK 
Reproducibility NOT OK 
= Horrat is the ratio between the established rsdR and the predicted rsdR 
Table 12: Horrat ratios of the virginiamycin collaborative study (without Grubbs' and Cochran 
outliers) 
Mean (mgAg), 
after discarding 
outliers1 
Predicted rsdR (%) Established rsdR Horrat2 Conclusion 
0,54 
1,62 
17,555 
14,879 
56 
69,4 
3,20 
4,67 
Reproducibility NOT OK 
Reproducibility NOT OK 
1
 = outliers are lab 31 (one of the 2 ppm samples) and lab 37 (all samples) 
2
 = Horrat is the ratio between the established rsdR and the predicted rsdR 
From the values for rsdr and rsdR it can be concluded that both the repeatability and the 
reproducibility of the method are unsatisfactory high. This is in accordance with the results of task 
1 (method development and within-lab validation) and task 2 (between-lab validation) of the project 
and the conclusions drawn at the kick-off meeting (see par. 1). Consequently, the application of 
the method is restricted to semi-quantitative use. 
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5.2 Blank samples 
The results for the two blank feed samples (broiler and piglet feed) are reported separately in 
Tables 13 and 14. 
Table 13: Reported results of the participants for the blank samples of broiler feed 
Partner 
11 
15 
21 
22 
25 
26** 
28*** 
29 
31 
32 
37 
38 
Blank sample 1 
Result 1 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mg/kg 
Nd 
0,4 
<L0D 
0 
< 0,5 mg/kg 
Negative 
ND 
0 
Result 2 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mgAg 
Nd 
0,3 
<LOD 
0 
< 0,5 mgAg 
Negative 
ND 
0 
Blank sample 2 
Result 1 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mgAg 
Nd 
0,3 
<LOD 
0 
< 0,5 mgAg 
Negative 
ND 
0 
Result 2 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mgAg 
Nd 
0,2 
<LOD 
0 
< 0,5 mgAg 
Negative 
ND 
0 
Lab 26 estimated their limit 
Lab 28 estimated their limit 
of quantification (LOQ) at 0,2 mgAg-
of detection (LOD) at 0,12 mgAg-
Note: lab 32 estimated concentrations for the 2 samples were 0,02 and 0,03 
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Table 14: Reported results of the participants for the blank samples of piglet feed 
Partner 
11 
15 
21 
22 
25 
26** 
28*** 
29 
31 
32 
37 
38 
Blank sample 1 
Result 1 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mgAg 
Nd* 
0,3 
<LOD 
0 
< 0,5 mgAg 
Negative 
Lost sample 
0 
Result 2 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mgAg 
Nd* 
0,2 
<LOD 
0 
< 0,5 mgAg 
Negative 
ND 
0 
Blank sample 2 
Result 1 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mgAg 
Nd* 
0,3 
Around LOD 
0 
< 0,5 mgAg 
Negative 
ND 
0 
Result 2 
OmgAg 
Blank 
0,0 N.D. 
< 0,5 mgAg 
Nd* 
0,3 
<LOD 
0 
< 0,5 mgAg 
Negative 
ND 
0 
revealed a high background 
Lab 26 estimated their limit 
Lab 28 estimated their limit 
that compromised analyte detection 
of quantification (LOQ) at 0,2 mgAg 
of detection (LOD) at 0,12 mgAg 
Note: lab 32 estimated concentrations for the 2 samples were 0,12 and 0,14 
Out of 12 laboratories, one lab (nr. 26) reported positive results for both feeds. These values are 
lower by a factor of 3-4 than the values obtained by this lab for the 2 mgAg sample. Lab 25 
reported a background in the piglet feed that roughly corresponds to a signal of 0,05 mgAg-
These values are lower by a factor of 4 than the values obtained for the 2 mgAg sample. 
The laboratories that did not report a quantitative value for the blank samples used various 
descriptions (see Table 13 and 14), viz. "blank", "< 0,5 mgAg", "nd", "<L0D", "negative", "0". In 
order to get more insight in the meaning of these descriptions, these laboratories were asked to 
give information on the signals measured in the blank samples. From the information obtained 
until now, it is not possible to draw clear conclusions about this point. The information tends to 
indicate that some laboratories only measure a very small signal (if any) at the retention time of 
virginiamycin while others measure a relatively large signal (see the chromatograms in Appendix 
6), like laboratories 25 and 26. Most probably, these differences are caused by differences in the 
chromatographic conditions. Due to this diversity it was not possible to model the statistical error 
of the signals measured in blank samples. For this reason it is not possible to draw conclusions 
about the occurrence of false-negative results when the method is applied for screening at 
contents lower than 2 mgAg-
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5.3 Recoveries 
Table 15: Recoveries 
Partner 
11 
15 
21 
22 
25 
26 
28 
29 
31 
32 
37 
38 
Recovery 1 in % 
76 
63 
68 
82 
43 
87 
78 
54 
56 
42 
43 
60 
Recovery 2 in % 
80 
65 
67 
79 
85 
51 
37 
42 
43 
37 
93 
Recovery 3 in % 
45 
Recovery average 
in% 
78 
64 
68 
80 
43 
86 
65 
46 
48 
43 
40 
77 
Mean recoveries ranged from 40-86%. These results are in accordance with the results obtained 
previously in tasks 1 and 2 of the project (see chapter 1). 
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5.4 Remarks 
Table 16: Remarks made by the partners 
Partner 
11 
15 
21 
22 
25 
26 
28 
Remarks 
No remarks 
No remarks 
- We would like to know why in the final calculation you don't consider the water 
volume used to wet the feed at the beginning of the extraction step. 
- We had some problems during the elution of the Sep-Pak Silica cartridges into 
the oasis HLB ones. In fact the Oasis HLB run dry before the elution solvent has 
passed through the Sep-Pak Silica cartridges, (critical) 
- The virginiamycin content was calculated from the peak area by reference to the 
calibration graph. 
- The virginiamycin contents (mgAg) are expressed as microbiological activities. 
The extraction procedures on spiked samples at 10 ppm gave a recovery rate of 
around 43%. The absolute values found should be corrected by the recovery factor 
above mentioned. 
Of the following samples the peak area of the analyte found was lower than that of 
the standard solution 1 ug/ml: 
256850 0,21** 0,21** 
256931 0,22** 0,22** 
- The extraction and clean-up method procedure was straight forward and easy to 
follow 
- The details concerning the preparation of the standards need some clarification 
- The final volume of 500 ul could be increased to 1 ml. This volume is very small. 
It is our practice to inject samples twice when there is no internal standard 
present. As a result the chromatography had to be re-run with the extract being 
placed into liners in the autosample vials. 
Sample preparation: 5 ml of water is not sufficient for a complete moistering of 
some feed samples -> it seems to be better to increase this volume and to optimise 
the volume of extraction solvent. 
HPLC-determination: 
There is no complete base line separation of the virginiamycin peak even after 11 
minutes of RT for the first analysis section! The chromatograms are very bad. It is 
very difficult to quantify and to calibrate accurately with standard solutions, which 
have very nice chromatograms. It seems to be better to quantify with spiked 
samples (matrix calibration). This is more convenient for residue analysis. 
Analysis with another column type didn't give nice HPLC-separation for virginiamycin. 
This determination method is not satisfactory optimised! 
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Partner 
29 
31 
32 
37 
38 
Remarks 
- We analysed several times the samples you sent, and we couldn't agree more 
about the lack of homogeneity within the same sample. 
- As for recovery rates, we had great difficulties concerning your BLANK sample. 
We got better results when we spiked two different broiler feeds at the level of 2 
mgAg (49% and 64%) and two different bull feeds at the level of 5 mgAg (89% 
and 100%), probably because of the type of feed matrix. 
- As for step 6.4.2, we never got a Na2S04 pellet, but we always added the 5 ml 
of anhydrous ethyl acetate/n-hexane 1:1 v/v, as recommended in the protocol. 
- Finally, as for step 6.4.7, the residues were reconstituted in 1,0 ml of HPLC 
mobile phase, instead of 0,5 ml as recommended. This volume wasn't enough 
for the needle (in the HPLC) to get liquid injected. So, in step 7 - Expression of 
results - Vt is 1,0 ml instead of 0,5 ml. 
- The values sent weren't corrected for the recovery rate. 
- The applied LOQ for the method is 0,5 mgAg. 
- All quantitive results are based on peak height. A minor interference at Rt ca. 
11,35 min. made this approach necessary. 
No remarks 
The biggest difficulty we had was at the elution from Sep-Pak Silica to Oasis HLB 
cartridge stage. In order to elute from the Silica Sep-Pak it was necessary to have a 
high vacuum and positive pressure (manually applied with syringe). 
Please note that samples labelled as 386860 and 386947 has been quantified 
around our Limit of Determination (LD= 0,6 mgAg). 
5.5 Special requests 
5.5.1 Microbiological analysis 
The following partners performed microbiological analyses on the feed samples, applying the 
official EU-method (Directive 84/4/EEC): 
- Rijksontledingslaboratorium (ROD, Tervuren, Belgium; K. Haustraete, A. Fontaine. 
- Staatliche Landwirtschaftliche Untersuchungs- und Forschungsanstalt (LUFA) Augustenberg, 
Germany; A. Thalmann, K. Wagner 
Rijksontledingslaboratorium (ROD measured a recovery of 94 % (level: 10 mgAg). 
Staatliche Landwirtschaftliche Untersuchungs- und Forschungsanstalt (LUFA) Augustenberg didn't 
report the recovery. 
Both laboratories didn't report remarks. 
The results of the analysed samples are reported in Table 15. 
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Table 17: Results of the samples analysed with the microbiological method 
Partner 
Sample content 
(mgAg) 
Blank piglet (0) 
Blank piglet (0) 
Blank broiler (0) 
Blank broiler (0) 
2 
2 
5 
5 
Rijksontledingslaboratorium (ROL), 
Tervuren, Belgium 
Result 1 (mgAg) 
<1 
<1 
<1 
<1 
1,20 
1,25 
2,79 
3,38 
Result 2 (mgAg) 
<1 
<1 
<1 
<1 
1,46 
1,06 
3,09 
2,91 
Staatliche Landwirtschaftliche 
Untersuchungs- und 
Forschungsanstalt (LUFA) 
Augustenberg, Germany 
Result (mgAg) 
0,0 
0,0 
0,0 
0,0 
1,7 
0,0 
2,5 
2,1 
The values obtained by ROL are higher than the mean values obtained with the CANFAS method. 
The negative results obtained by LUFA Augustenberg for one of the 2 mgAg samples indicate 
that at this low content, problems may be encountered with the sensitivity of the method. 
5.5.2 LC-MS/MS 
The following partner performed the analysis by LC-MS/MS 
- Departement voor Kwaliteit van Dierlijke Producten (DVK-CLO), Melle, Belgium; H. de Ruyck, 
H. de Ridder, L. Batjoens, P. de Neve 
The mobile phase used was as described in the method. The HPLC column used was an Alltima 
CI 8,150x2,1 mm, 5 um (Alltech). 
Reported recovery results: 82% and 64% (average 73%) 
Remarks of DVK-CLO to this method: 
For LC-MS/MS analysis it is recommended to use an internal standard for compensation of 
shifted ionisation. 
The analyses are done with electrospray ionisation, the sensitivity is not so high, but high 
enough for this purpose of determining such high virginiamycin levels. 
MS-conditions: see tune page report. 
Diagnostic ions: -parent M+l= 526,3 
-daughters M+l= (508,4), 354,8, 337,3 
->see spectra of full scan, daughter scan 
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The results of the analysed samples are reported in Table 18. 
Appendix 7 contains the completed questionnaire, applied LC-MS-conditions and representative 
mass spectra. 
The mass spectra of the broiler feed containing 2 mg/kg virginiamycin and the blind blank feed 
clearly show the improvements in selectivity and sensitivity compared tot the LC-UV method. 
Table 18: Results of the samples analysed with LC-MS/MS 
Sample content (mg/kg) 
Blank piglet (0) 
Blank piglet (0) 
Blank broiler (0) 
Blank broiler (0) 
2 
2 
5 
5 
Result 1 (mgAg) 
<L0D 
<L0D 
<L0D 
<LOD 
1,49 
1,36 
3,09 
2,40 
Result 2 (mgAg) 
<LOD 
<LOD 
<LOD 
<LOD 
1,07 
1,32 
1,51 
2,92 
The values obtained with LC-MS are higher than the mean values obtained with the CANFAS 
method (and also higher than the values obtained by DVK-CLO with the CANFAS method). While 
the same sample pre-treatment is applied for LC-UV and LC-MS this result cannot be explained. 
26 
6 EVALUATION AND CONCLUSIONS 
From the results of the collaborative studies it can be concluded that the repeatability and the 
reproducibility of the method are unsatisfactory. The measurement uncertainty of quantitative 
results is much larger than generally considered as acceptable. Thus, the applicability of the 
method is restricted to semi-quantitative use, which means that any quantitative result should only 
be reported together with a clear statement of the measurement uncertainty. This is in 
accordance with the results of task 1 (method development and within-lab validation) and task 2 
(between-lab validation) of the project and the conclusions drawn at the kick-off meeting. 
From the results it can be concluded that the method is suitable as a screening method to 
discriminate between positive samples containing 2 mgAg virginiamycin (or more) and negative 
samples. From the information obtained in this collaborative study it is not possible to deduce if 
the method is also suited to discriminate between samples containing 1 mgAg (the target value 
from the Project Plan) and negative samples. 
The results of the collaborative study were evaluated in a meeting in Tervuren (Belgium) on June 
19-20, 2001. 
After thorough discussion the panel decided to discard the results of lab 37 from the statistical 
evaluation. This decision is primarily based on the Grubbs outliers at all levels and supported by 
the chromatographic results. 
Based on the unsatisfactory results for repeatability, reproducibility and recovery (see par. 5.1, 
Tables 6 and 8) it is concluded that the method is only suitable as a semi-quantitative screening 
method. The method can discriminate between positive samples containing 2 mg/kg and blank 
samples but it is uncertain if all laboratories could discriminate between samples containing 1 
mgAg and blank samples. 
The method will not be recommended for adoption as an official method. It was agreed, also by 
mrs. Dyanne Bennink (scientific officer), that no further work will be done in the CANFAS-project. 
New work will be started in SIMBAG-FEED, taking into account the results of the CANFAS-project. 
The following remarks, related to the method description have been accepted: 
- Lab 26, second remark 
- Lab 26, third remark, par. 6.4.7 of the method: the option will be described to reconstitute 
the residue in 1 ml HPLC mobile phase in stead of 0.5 ml. 
The method description will be modified and the final method, together with the results of the 
collaborative study will be sent to the European Commission (CEMA). 
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APPENDIX 1 
Letter with instructions, sent with the samples (with five annexes) 
cc. Driessen,/! de Joj 
Dear colleague, 
Please find enclosed the samples for the collaborative study for virginiamycin: 
• 8 feed samples, with the text "additive: VIRGINIAMYCIN" and with a sample code; 
these samples constitute 2 blind duplicates of feed samples containing 
virginiamycin (contents in the range between 1 and 5 mg/kg) and 2 blind duplicates 
of a blank feed. 
The samples must be analysed in duplicate. 
DATE 
2 October 2000 
SUBJECT 
collaborative ttudy CAf 
virginiamycin 71.316.2 
ENCLOSURE!!) 
S 
OUR REFERENCE 
00/0022095 
HANOLED BY 
Dr. J. de Jong 
DIRECT (TELEPHONE! LINE 
+31 317 47 55 81 
EMAIL 
j.dejong®RIKILT.WAG-U 
For recovery purposes we have included a blank sample, with the text "blank feed for 
virginiamycin recovery purposes". 
The method which has to be used is included as Annex 1 (please note that this method is 
a modifieo'version of the method which was distributed prior to the kick-off meeting). 
Annex 2 contains the reporting form. This form will also be send to you by E-mail as an 
Excel 5.0 file. We strongly prefer to get the results back in electronic form by E-mail 
(please send the results to the following E-mail address: j.j.m.driessen@rikilt.wag-ur.nl). 
Of course you can also fill in the form and send it by fax or normal mail. 
The deadline for reporting the results is 8 December 2000. 
Annex 3 contains instructions for handling (milling, storage) of the samples. 
Annex 4 is a questionnaire. We kindly ask you to give us information about the 
experimental conditions, recoveries, etc.. On this form you can also give your remarks 
about the method. 
RIKILT 
State Institute for Quail' 
Control of Agricultural 
Product« 
P.O.Box 230 
6700 AB Wageningen 
The Netherlands 
VISITORS' ADDRESS 
Building no. 123 
Borntesteeg 45 
6708 PD Wageningen 
TELEPHONE 
+31 317 47 54 00 
FAX 
+31 317 41 77 17 
CHAMBER OF COMMERCE REGISTRA* 
09098104 te Arnhem 
THE INTERNET 
r.rikilt.wageningen-' 
Annex 5 contains information about special requests. We hope that, next to the regular 
determinations, you are prepared to volunteer to do extra work with LC-MS. 
The reference standard of virginiamycin which has to be used (98162-QCS) was already 
sent to you with my letter of 31 May 2000. This reference standard has a 
microbiological potency of 225 % or 2250 ug/mg. 
We wish you and your colleagues the best with the collaborative studies. If you have any 
questions, do not hesitate to contact us. 
Kind regards, 
dr. Jacob de Jong 
CANFAS coordinator 
ing. J.J.M. Driessen 
co-ordinator CANFAS 
collaborative studies 
cc mrs. I. de Froidmont-Görtz, European Commission, DG Research, CII/3, Brussels 
RIKILT 
State Institute for Quality Contr 
of Agricultural Products 
DATE 
2 October 2000 
OUR REFERENCE 
00/0022095 
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CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 1 - Description of the method 
CANFAS/VIRG/26092000/C. HAJEE 
Detection of Virginiamycin in animal feeding stuffs by a High 
Performance Liquid Chromatographic method with UV 
detection 
1 INTRODUCTION 
Virginiamycin has been banned recently as a feed additive. Consequently, in addition to microbiological 
screening methods, there is a need for instrumental analytical methods that are capable of detecting 
Virginiamycin in feeding stuffs at levels well below additive level. 
2 SCOPE AND FIELD OF APPLICATION 
This operating procedure describes a method for the detection of the Virginiamycin Ml as a marker analyte 
for the total Virginiamycin content in animal feeding stuffs using high performance liquid chromatography 
and UV detection at 235 nm. The scope of the method is screening for the presence of virginiamycin in 
animal feeding stuffs at sub-additive levels. 
Applicability of this method has been demonstrated for pigs, piglets, calves and poultry feed containing at 
least 1 mgAg Virginiamycin. 
Cattle feed containing at least 3 mgAg Virginiamycin. 
Sows and laying hens feed containing 4 mgAg Virginiamycin. 
Throughout this SOP the Virginiamycin content is expressed as mg/kg based on the microbiological activity, 
determined with Virginiamycin Ml as target compound. To obtain the content expressed on a weight to 
weight basis (w/to), the microbiological activity based content has to be divided by the microbiological 
potency of the reference standard material (usually around 220 %). 
3 PRINCIPLE 
Virginiamycin Ml is extracted from wetted feeding stuffs with ethyl acetate in an ultrasonic bath. A part of 
the extract is purified with tandem Solid Phase Extraction (SPE) using Silica and OASIS HLB cartridges. The 
eluate of the solid phase extraction is evaporated under nitrogen and the residue is dissolved in HPLC 
eluent. From this fraction a part is injected on a liquid chromatography system with a 'reversed phase' 
column. Isocratic elution is used and UV detection at 235 nm is applied. 
^muotufJH 
rage t. ui 
RI KILT 
, • • f rin in - ™ T " " " d «nimal feeding stuffs by HPLC-UV ; 
4 REAGENTS AND MATERIALS 
Only use reagents of recognised analytical grade. 
4.1.1 Water, HPLC quality. Conductivity < 10 Mfl.cm2 
4.1.2 Acetonitrile, HPLC gradient grade 
4.1.3 Methanol, HPLC gradient grade 
4.1.4 Ethyl acetate, HPLC gradient grade 
41.5 rvHexane, GR 
4.1.6 Sodium sulphate, anhydrous GR for analysis 
4.1.7 Ammonium acetate, GR 
4.1.8 Formic Acid, 100%, GR 
ÏÏ. ^ S c S P E c a « g , 6 9 0 m e W ä « e , W A T 0 5 1 9 0 0 „ e ^ d * a 
solvent reservoir of 20 ml 
£111 OASIS HLB SPE cartridge, 60 mg, 3 rnL, (Waters, WAT 094226) 
t o - o s a b , p o , y p r o p ^ 
4 : U 3 Disposab.epo.yprop^neUm.tub.sw^screwcapCGreiner.Germany^ 
41.14 Sample vials used for HPLC (1.2 ml) 
4115 SepPak vac adapter (Waters, WAT 054260) 
4J*16 Sep-Pak classic male/male adapter (Waters, WAT 024310) 
4117 Disposable polypropylene syringes, 5 ml 
4.2 Solutions 
and store the solution on anhydrous sodium sulphate (4.1.6). 
4.2.2 Ammonium acetate, 1M
 n , v o | u m e t r i c f,askt dissolve and 
Weigh 38.5 gram ammomum acetate (4.1.7), transter 
make up to 500 ml with water (4.1.1). 
4.2.3 Ammonium acetate b ^ e | ° : ^ M ' ^ g 0 ( > m , w a t e r (4.1.1) in a lOOOml volumetric flask. 
UîâJL£?$%£%££"* p« « ' :3 vA-Mi* 250 m'me,hano, ,4-1-31 * 7 5 ° 
ml a l o r t » acetate buffer 0.1 M pH 4.0 (4.2.3). 
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4.2.6 Mobile phase for HPLC 
Water / acetonitrile / acid 600:400:3 v/v/v. Mix 600 ml water (4.1.1) with 400 ml acetonitrile (4.1.2) 
and 3 ml formic acid (4.1.8). Filter through a 0.22 urn filter (4.1.19) and degas with helium prior to 
usage. 
4.3 A n t r a l standards 
4.3.1 Virginiamycin reference standard 
The reference standard should preferably be supplied with a certificate of analysis containing at least 
the chemical purity and the guaranteed microbiological potency/activity (Pfizer, Pharmaceutical 
Group, Antibiotics Plant, Rixenart, Belgium). 
The reference mix usually contains about 57% Virginiamycin Ml and 19% Virginiamycin SI and has a 
microbiological potency of around 220%. 
4.4 preparation of standard solutions 
4.4.1 Stock solution virginiamycin 500 pg/ml m.a. 
Weigh approximately 10 mg (± 0.1 mg) of Virginiamycin reference standard (4.3.1) (take account of 
the w/w-purity and of the microbiological potency of the reference standard). Dissolve the 
virginiamycin in an appropriate volume methanol (4.1.3) to produce a concentration of 500 ug/ml 
based on microbiological activity (take account of the w/w-purity and of the microbiological potency 
of the reference standard). The appropriate volume methanol can be weighed taking account of the 
density (1L methanol =0.79 kg). 
This solution can be stored for 2 months at a temperature of 4 °C (± 4 °C). 
4.4.2 Diluted stock solution Virginiamycin 50 ug/ml 
Pipet 1000 pi stock solution (4.4.1) in a 10.00-ml volumetric flask, adjust to volume with LC mobile 
phase (4.2.6) and mix. This solution can be stored for one week at a temperature of 4 °C (± 4 °C). 
4.4.3 Spiking solution Virginiamycin 50 ug/ml 
Pipet 1000 pi stock solution (4.4.1) in a 10.00-ml volumetric flask, adjust to volume with methanol 
(4.1.3) and mix. This solution can be stored for one week at a temperature of 4 °C (± 4 °C). 
4.4.4 Calibration solutions used for the calibration curve 
These solutions can be stored and are stable for one week in a refrigerator at a temperature of 4 °C 
(±4CC). 
4.4.4.1 Calibration solution 1.0 pg/ml (* 0.2 mg/kg in feed assuming 100% recovery) 
Pipet 200 pi of diluted stock solution (4.4.2) into a 10.0-ml volumetric flask, adjust to volume with 
HPLC mobile phase (4.2.6) and mix thoroughly. 
4.4.4.2 Calibration solution 2.5 ug/ml (« 0.5 mg/kg in feed assuming 100% recovery) 
Pipet 500 pi of diluted stock solution (4.4.2) into a 10.0-ml volumetric flask, adjust to volume with 
HPLC mobile phase (4.2.6) and mix thoroughly. 
4.4.4.3 Calibration solution 5.0 pg/ml {« 1.0 mg/kg in feed assuming 100% recovery) 
Pipet 1000 pi of diluted stock solution (4.4.2) into a 10.0-ml volumetric flask, adjust to volume 
with HPLC mobile phase (4.2.6) and mix thoroughly. 
4.4.4.4 Calibration solution 10.0 pg/ml {= 2.0 mgAg in feed assuming 100% recovery) 
Pipet 2000 pi of diluted stock solution (4.4.2) into a 10.0-ml volumetric flask, adjust to volume 
with HPLC mobile phase (4.2.6) and mix thoroughly. 
4.4.4.5 Calibration solution 25.0 pg/ml (• 5.0 mg/kg in feed assuming 100% recovery) 
Pipet 5000 pi of diluted stock solution (4.4.2) into a 10.0-ml volumetric flask, adjust to volume 
with HPLC mobile phase (4.2.6) and mix thoroughly. 
4.4.4.6 Calibration solution 50.0 pg/ml (* 10.0 mg/kg in feed assuming 100% recovery) 
Identical to diluted stock solution (4.4.2). 
NOTE: Sections 4.4.2- 4.4.4 have been updated since the kick-off meeting. 
WlIkUDIUfJH 
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5 APPARATUS 
Common laboratory apparatus and, in particular, the following: 
5.1 YprfrY shaker (for example IKA fibrofix. VF1) 
5.2 | fflrafinnir hath (for example Branson art. 2210) 
5.3 Ontr'f"Pp w i t n Preferably at least 24 positions for 50-ml tubes (for example MSF Mistral 3QQr) f ) 
5.4 RPF unit suitable for 12 or more cartridges equipped with a vacuum numo 
5.5 Fvfipnratinn station (for example Pierce) 
5.5.1 React' Therm (art.no. 18790) 
5.5.2 React'Vap (art.no 18780) 
5.6 PH meter (fnr example Schott art. CG 840) 
5.7 High performance liquid chromatography system consisting of the following: 
5.7.1 An autosampler or manual injector set to inject 100 ul. 
5.7.2 A pump set to deliver a constant mobile phase flow rate of 1.0 ml/min. 
5.7.3 A guard column packed with pellicular C18 material 
5.7.4 An analytical column, length 250 mm, internal diameter 4.6 mm, packed with 5-pm 
Lichrospher C18 or Hypers« BDS C18 stationary phase particle material (for instance 
Chrompack) 
5.7.5 A detector allowing the measurement of absorbançe of UV light at a wavelength of 235 nm, 
with integrator / recorder. 
The resulting average retention time for Vlrginiamycin Ml is 10 min ± 2 min. 
5.8 Mill fn P rpParp laboratory samples with a maximum nartide si7e nf 1 mm 
6 PROCEDURE 
6.1 Preparation of test samples 
Feed test samples must be milled and mixed prior to assay. Grind feed samples through a mill (5.8) 
equipped with a 1-mm screen. After milling, mix the entire sample thoroughly. Store the sample in such 
a way that deterioration and changes in its composition are prevented. 
6.2 Weighing test portion feed samples 
Feed test samples should be at room temperature before taking into the procedure. Feed test samples 
are homogenised manually prior to weighing. 
6.2.1 Blank feed 
For the performance of the recovery test (6.2.2) a blank feed should be analysed to check that 
neither virginiamycin nor interfering substances are present. The blank feed should be similar in type 
to that of the sample and virginiamycin or interfering substances should not be detected. 
6.2.2 Recovery test 
A recovery test should be carried out by analysing the blank feed that has been fortified by addition 
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of a quantity of virginiamycin, similar to that present in the sample. Weigh to the nearest 0.01 g, 5 g 
feed test sample (6.1) into a 50-ml tube (4.1.12). To fortify at a level of 4mgAg, transfer 400 pi 
spiking solution (4.4.3) to the blank feed, mix thoroughly, for instance with a vortex mixer (5.1) and 
leave for 10 minutes mixing again several times before proceeding with the exfraction procedure 
(6.3). 
Alternatively, if a blank feed similar in type to that of the sample is not available (see 6.2.1), a 
recovery test can be performed by means of the standard addition method. In this case, the sample 
to be analysed is fortified with a quantity of virginiamycin similar to that already present in the 
sample. This sample is analysed together with the unfortified sample and the recovery can be 
calculated by subtraction. 
6.2.3 Feed test samples 
Weigh to the nearest 0.01 g, 5 g feed test sample (6.1) into a 5f>ml tube (4.1.12). 
6.3 FxtRf tinn procedure 
Add 5 ml water (4.1.1), mix vigorously, for instance with a vortex mixer (5.1), to evenly distribute the 
water in the feed, wait for 10-15 minutes and mix vigorously again. The water should be taken up 
completely by and distibuted evenly in the feed (critical). 
Add 20 ml ethyl acetate (4.1.4), cap the tube, mix ± 30 sec vigorously for instance with a vortex mixer 
(5.1), wait for 10 minutes and mix vigorously again. The feed layer should be loosely distributed in the 
ethyl acetate layer (critical). 
Place the tube for 30 min in an ultrasonic bath (5.2). Take the tube(s) out of the ultrasonic bath and 
shake by hand two to three times during the ultrasonication time. 
Centrifuge (5.3) for 10 min at ambient temperature at 3500 rpm (= 3000 *g). 
Weigh approximately 5 gram anhydrous sodium sulphate (4.1.6) in a clean 50-ml polypropylene tube 
(4.1.12). 
Transfer 10 ml of the upper layer i.e. the ethyl acetate fraction to the clean polypropylene tube 
containing the anhydrous sodium sulphate. 
Add 10 ml n-hexane (4.1.5) to the 10 ml ethyl acetate extract and mix, for instance wfth a vortex mixer 
(5.1). Centrifuge (5.3) for 5 min at ambient temperature at 3500 rpm (=3000 *g). 
6.4 SPF samnle clean-up procedure 
6.4.1 Conditioning of the Sep-Pak Silica cartridge 
Attach the adapter (4.1.16) and a 20-mL syringe reservoir (4.1.18) to the Sep-Pak Silica cartridge 
(4.1.10) and place it on the SPE unit (5.4). Rinse the Sep-Pak Silica cartridge with 2.5 ml anhydrous 
ethyl acetate / n-hexane 1:1 vA (4.2.1 ). 
6.4.2 Application of the extract to the Sep-Pak Silica cartridge 
Carefully decant the clear supernatant and pass it through the conditioned Sep-Pak Silica cartridge. 
Do not allow the cartridge to run dry! Solvent flow not higher than 2 ml/min. 
Rinse the sodium sulphate pellet by adding 5 ml anhydrous ethyl acetate / n-hexane 1:1 v/V (4.2.1) 
to the tube and mix for instance on a vortex mixer (5.1). 
Centrifuge (5.3) for 5 min at ambient temperature at 3500 rpm (=3000*g). 
Isolate the supernatant and apply it to the Sep-Pak Silica cartridge. After the liquid has completely 
passed through the Sep-Pak Silica cartridge, allow the cartridge to run dry. Wash the cartridge with 2 
ml acetonitrile (4.1.2). Allow the cartridge to run dry. Remove and discard the syringe reservoir from 
the cartridge. Dry the cartridge for 30 min by applying vacuum with the SPE unit. 
6.4.3 Pre-treatrnent of the OASIS HLB Cartridge 
Place an OASIS HLB cartridge (4.1.11) on the SPE unit (5.4). Successively activate the OASIS HLB 
cartridge with 1 ml methanol (4.1.3) and condition with 1 ml ammonium acetate buffer 0.1 M, pH 4.0 
(4.2.3) 
6.4.4 Elution of the Sep-Pak Silica cartridge 
w.^ rukmurjn 
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Attach a 5-mL syringe reservoir (4.1.17) to the dried Sep-Pak Silica cartridge (6.4.2) and connect it 
to the conditioned OASIS HLB cartridge (6.4.3) (Sep-Pak Silica on top) using an SPE adapter 
(4.1.15). 
Elute the dried Sep-Pak Silica cartridge with 5 ml elution solvent (4.2.4) and allow the eluate to pass 
directly through the OASIS HLB cartridge. Solvent flow not higher than 2 ml /min. The analyte is 
retained on the OASIS HLB cartridge. Disconnect and discard the Sep-Pak Silica cartridge. 
6.4.5 Elution of the OASIS HLB cartridge 
Wash the OASIS HLB cartridge with 2.5 ml washing solvent (4.2.5). Allow the OASIS HLB cartridges 
to run dry. Elute the OASIS HLB cartridge with two 2.5-ml volumes ethyl acetate (4.1.4) and collect 
both portions in the same 14-ml polypropylene tube (4.1.13). 
6.4.6 Evaporation of the solvents 
Place the polypropylene tube containing the ethyl acetate fractions obtained at 6.4.5, in the 
evaporation station (5.5). Adjust the temperature to 50 °C and evaporate the ethyl acetate fractions 
under a mild nitrogen gas flow (argon or helium can be used also). 
6.4.7 Reconstitution of the residues 
Reconstitute the residues in 0.5 ml HPLC mobile phase (4.2.6) and mix vigorously, for instance on a 
vortex mixer (5.1). Ultrasonicate the reconstituted sample solution for 5 minutes and mix again. In 
case an autosampler is used tranfer the sample solution to an autosampler vial of suitable 
dimensions. 
6.5 HPLC determination 
6.5.1 Parameters 
The following conditions are offered for guidance, other conditions may be used provided that they 
give equivalent results. 
Liquid chromatographic column (5.7.4): 250 mm Q4.6 mm, üchrospher C18 or Hypersil BDS C18, 
5 pm packing, or equivalent. 
Mobile phase (4.2.6): Mixture of acetonitrile (4.1.2), water (4.1.1) and formic acid (4.1.8), 
400+600+3 (v+v+v). 
Row rate: 1.0 ml/tain. 
Detection wavelength: 235 nm. 
Injection volume: 100 uL. 
Analysis time: 40 min 
Check the stability of the chromatographic system, injecting several times the calibration solution (0) 
containing 10.0 ug/mL virginiamycin, until constant peak areas (heights) and retention times are 
achieved. 
6.5.2 Chromatographic series 
The sequence in a chromatographic series should be injection of calibration solutions (4.4.3), blank 
HPLC solvent (4.2.6), blank feed (6.2.1), recovery samples (6.2.2), blank HPLC solvent (4.2.6), feed 
samples (6.4.7) and calibration solutions (4.4.3). 
6.5.2.1 Calibration graph 
Inject each calibration solution (4.4.3) and determine the peak areas (heights) for each 
concentration. Plot a calibration graph using the peak areas (heights) of the calibration solutions 
as the ordinates and the corresponding concentrations in ug/mL as the abscissae. 
6.5.2.2 Sample solution 
inject the sample extracts (6.4.7) using the same injection volume as taken for the calibration 
solutions and determine the mean peak height (area) of the virginiamycin Ml peak. 
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7 EXPRESSION OF RESULTS 
Expression of the results is merely an estimation of the virginiamycin content The method is 
intended for screening purposes only. 
From the area (height) of the virginiamycin M l peak of the sample solution determine the virginiamycin 
concentration of the sample solution in ug/mL by reference to the calibration graph (6.5.2.1). 
Use the following formula to estimate the virginiamycin content W in mg/kg in the feed samples: 
W = content of Virginiamycin in mg/kg m.a. (not corrected for recovery) 
c, = virginiamycin concentration in sample solution (ug/mL) 
m = test portion of animal feed in gram (= 5 g) 
Ve = volume of ethyl acetate in extraction in ml (= 20 ml) 
VjpE = volume of feed extract taken to SPE clean up in ml (= 10 ml) 
Vt = volume of sample extract in ml (= 0.5 ml) 
Annex 2 
CANFAS 
•Development and Validation of HPLC-methods for the official control of 
•Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Date of analysis: [ 
Analyte: [ VIRGINIAMYCIN 
Unit 
Sample code 
316838 
316843 
316872 
316874 
316897 
316932 
316940 
316942 
Result 1 
(ma/kg) 
• 
. 
Result 2 
(mg/kg) 
I 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 3 - Instructions for handling of the samples 
1. Storage 
Store the samples at room temperature until analysis. 
2. Milling 
Grind the feed samples with a mill equipped with a 1 mm screen 
3. Mixing of the test samples before weighing 
Mix the entire sample thoroughly 
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Annex 4 - Questionnaire 
Laboratory: 
Contact person: 
Date(s) of analysis: 
^Inflations for t h p * t o r k snlunnn f4.4.1): 
• Amount of virginiamycin reference standard weighed: mg 
• Volume of methanol: ml 
• Concentration of the stock solution: ug microbiological activity/ml 
Chromatnprftpfr'- conditions: 
• Column: 
• D As described in the method 
• D Other: 
• Mobile phase: 
• o As described in the method 
• D Other: 
• Row-rate: m|/min 
• Injection volume: ui 
• Retention time of virginiamycin Ml: min 
Chromatograph P'ease include representative chromatoerams of: 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Rernvprv results: 
• Percentage recovery: % 
• Single/duplicate determinations: D single o duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: mgAg 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Remarks /Comments (if necessary, continue on another page) : 
Please complete this questionnaire and return it together with representative chromatograms to: 
Ing. JJ.M. Driessen 
RIKILT 
P.O. Box 230 
6700 AE Wageningen 
The Netherlands 
Fax+31-317417717 
Thank you for your cooperation 
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Annex 5 - Special requests 
Volunteers are asked to do the following additional work: 
I CMS or LC-MS-MS ni the feed samples 
The extracts resulting from the LC-UV method can be used. If it is not possible to perform the LC-MS 
analysis directly, the extracts must be stored frozen. 
As an example, the conditions applied by RIKILT are described in the appendix attached. Representative 
mass spectra are included. 
Please report the results in a copy of annex 4 and give additional information on LC-MS models) applied, 
conditions, diagnostic ions, etc. Please include representative mass spectra. Please also state if it was 
possible to fulfil the criteria for confirmation as described in the document SANCO/1805/2000 (document 
on revision of criteria, Revision of Commission Decision 93/256/EC) 
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Figure 1. Example chromatograms of virginiamycin Ml in an extract of piglet feed spiked at LOQ 2.2 mgAe 
m.a. with virginiamycin obtained after injection into an LC system coupled to MS detection in A. single 
reaction monitoring (SRMJ L C-M& mode; B. single ion monitoring (SIM) L C-MS mode; and C. SIM Collision 
Induced Dissociation (CID) LC-MS mode 
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Composition of the feed samples 
BESTMIX '- Afdruk mengopdracht 
132.00 Vleeskuiken korrel 
Vleeskuiken korrel 
test Rikilt \/iWMflWWCJ^ IW &Mjl * y/y 
06/09/00 - IPC DIER BARNEVELD^' 
Grondstof 
Weegschaal DN 1 
Silo % Gewicht Tol. Cumul Gew. 
kg +/-Afw. kg 
460 Tapioca65%zetmeel 
77 Soja 45/46(arg/braz) 
Weegschaal DW 2 
145 Tarwe 
40 Mais 
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( 4) 30.00 
( 9) 23.20 
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l/t ' 
Vloeistof! 
'rem JcuiJcen Kijcut t 
96 Vet (soja-olie) 
100 Vet destr.<0.5%polym 
0) 
0) 
0) 
0) 
0) 
0) 
0) 
0) 
0.06 
0.14 
0.30 
0.60 
0.04 
1.00 
1. 
4, 
50 
80 
150.00 
116.00 
149.00 
27.80 
15.00 
0.30 
0.70 
1.50 
3.00 
0.20 
5.00 
»7.50 
24.00 
I 
Totaal : 
4.50 
3.48 
4.47 
0.83 
0.45 
0.00 
0.01 
0.02 
0.03 
0.00 
0.05 
0.23 
0.-72 
150.00 
266.00 
149.00 
176.80 
15.00 
0 
1 
2 
5 
5 
10, 
7 . 
3 1 . 
. 30 
. 00 
. 50 
.50 
.70 
.70 
50 
50 
Charge Charge 
• • • • 
,v.. 
.1/ 
• $ • 
c/ 
500.00 
RETOÜRPRODÜKT 
INSTELLINGEN 
T.R. : / W ^ / j ö ^ 
V.Z. : grof/(f|ià . . &J>... % 
Z.F. : . Jfeto. ... mm 
H.M. : fooögVlaag toeren 
kringloop : ja/^ë^ 
L.M. : voormengen ho. sec 
namengen 300. sec 
M.D. : ..TT.. l/h 
Meel temp 
Matrijs diam. 
K.P. 
Laagdikte Ko 
Zeef Ko 
Kruimelen 
• ÄT. *c ktind'kntf>Jo °c 
**» x S-* mm 
• * * . Amp 
• ~5Ö cm 
• Tc' """ 
ja/CHU> 
shti % 
/o 
BESTMIX - Af druk mengopdracht i j f t ^ 
- 06/09/00 - IPC DIER BARNEVELD 
260.00 Vleesstierenbrok . 
Vleesstierenbrok 18% z DHII 
Grondstof Silo % Gewicht Tol. Cumul Gew. 
kg +/-Afw. kg 
Weegschaal DW 1 
113 Zonbl.schr.290re ( 2) 1.50 
266 Raapschrt 340 g re ( 3) 15.00 
191 Tapioca66%zetmeel HP ( 4) 15.00 
Weegschaal DW 2 
64 Palmp.schil9rc (28) 15.00 
Bijstort SP4 
34 Lynzaad ( 0) 0.60 
84 Sojaschroot 49/3.5rc ( 0) 10.00 
Bijstort SP6 
10 Citruspulp ( 0) 13.00 
29 Kokossch. <100rv ( 0) 10.00 
107 Maisgl.USA Standaard ( 0) 10.40 
Bijstort SP7 
117 Krijt/kalksteen { 0) 0.90 
485 Zout ( 0) 0.10 
507 Prem stieren Rikilt ( 0) 1.00 
Vloeistoffen 
52 Melasse riet;<450 ( 0) 6.00 
100 Vet destr.<0.5%polym ( 0) 1.50 
7.50 
75.00 
75.00 
75.00 
3.00 
50.00 
65.00 
50.00 
52.00 
4.50 
0.50 
5.00 
0 .23 
2 . 2 5 
2 . 2 5 
2 . 2 5 
0.09 
1.50 
1.95 
1.50 
1.56 
0.05 
0.01 
0.05 
7 . 5 0 
8 2 . 5 0 
157.50 
7 5 . 0 0 
3 . W 
53.00 
30.00 j 0.90 
7.50 I 0.23 
Totaal : 
65 
115 
167 
4 
5 
10 . 
3 0 . 
3 7 . 
.00 
.00 
. 00 
.50 
.00 
.00 
,00 
50 
Charge charge 
. . / . 
..it.. 
• • • •#• 
.My 
5 0 0 . 0 0 
RETOURPRODUKT 
INSTELLINGEN 
T.R. 
V .Z . 
2 . P . 
H.M. 
L.M. 
M.D. 
W. SM 
grof/gffi . . .O? . . % 
. <-/* . • . . mm 
<fiooà/laag toeren 
kringloop : j a / ^ e ^ 
voormengen PA. sec 
namengen 30O. 
JSsr.. i/h 
sec 
Meel temp 
Matrijs diam. 
K.P. 
Laagdikte Ko 
Zeef Ko 
Kruimelen 
HaCtnem 
VodU 
sé.. 
&S" X 
.Zff.. 
.?$• 
}a/igee 
W 
°c ka* 
•55. mm 
Amp 
cm 
mm 
P> 
% 
°/« 
o»dMe*if> }é °C 
APPENDIX 3 
Homogeneity of samples 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Homogeneity test collaborative study 
Additive : 
Product : 
Virginiamycin 
Feed sample: 2 ppm 
Date of determination : 
Sample 
18431 A 
18431 B 
18432 A 
18432 B 
18433 A 
18433 B 
18434 A 
18434B 
18435 A 
18435 B 
18436 A 
18436 B 
18437 A 
18437 B 
18438 A 
18438 B 
18439 A 
18439 B 
18440 A 
September 21 th, 
Content 
mg/kg 
1,01 
0,95 
0,98 
1,41 
0,57 
0,94 
1,59 
0,78 
0,75 
1,12 
1,09 
0,63 
0,73 
0,32 
0,78 
0,65 
0,78 
1,03 
1,75 
2000 
Duplicate 
average 
mg/kg 
0,98 
1,20 
0,76 
1,18 
0,94 
0,86 
0,53 
0,72 
0,91 
1,28 
18440 B 
Repeatability 
0,81 
tomogeneity 
Criterion : C V , » , ^ = < 60% 
average 
>D (between samples) 
ÏV (between samples) 
Srubb's test, single lower 
Srubb's test, single upper 
Srubb's test, double lower 
îrubb's test, double upper 
OK 
0,94 
0,24 
25,3 
1,716 
1,469 
0,4815 
0.5307 
Result Grubb's test 
no outlier"""""" 
no outlier 
n o Ol itli Arc 
no outliers 
»D (within samples) 
;V (within samples) 
(Sdr) 
(CV (%)) 
0,35 
37,4 
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CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Homogeneity test collaborative study 
Additive : 
Product : 
Virginiamycin 
Feed sample: 5 ppm 
Date of determination : 
Sample 
18841 A 
18841 B 
18842 A 
18842B 
18843 A 
18843B 
18844 A 
18844B 
18845 A 
18845 B 
18846 A 
18846B 
18847 A 
18847 B 
18848 A 
18848B 
18849 A 
18849 B 
18850 A 
18850 B 
September 22th, 
Content 
mg/kg 
1,16 
2,04 
1,46 
1,77 
2,71 
1.75 
2,10 
2,73 
1,42 
2,70 
2,11 
2,09 
1,81 
2,50 
2,06 
2,14 
3,01 
3,00 
2,61 
2,28 
2000 
Duplicate 
average 
mg/kg 
1,60 
1,62 
2,23 
2,42 
2,06 
2,10 
2,16 
2,10 
3,01 
2,44 
Homogeneity 
Criterion : CV,**,,«, = < 60% 
Average 
SD (between samples) 
CV (between samples) 
Grubb's test, single lower 
Grubb's test, single upper 
Grubb's test, double lower 
Grubb's test, double upper 
OK 
2,17 
0,41 
18,8 
1,408 
2,047 
0,4652 
0,3840 
Result Grubb's test 
no outlier 
no outlier 
no outliers 
no outliers 
Repeatability 
S D
 (within samples) 
£y (within samples) 
(sdr) 
(CV (%)) 
0,47 
21,6 
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APPENDIX 5 
Virginiamycin reference standard profile, identity and purity 
r 
P/tZCi 
PPG/MD Quality Operations 
Analytical Resource Group 
Pfizer Ine 
Eastern Point Road 
CERTIFICATE OF ANALYSIS 
REFERENCE STANDARD 
Virginiamycin 
LOT98162-QCS 
Purity: 225% or 2250 pg/mg Virginiamycin when used as is 
Manufacture Date: January 1998 
PARAMETER RESULT 
Appearance 
H PLC - Identification 
IR - Identification 
Microbial Assay 
LOD 
Residue on Ignition 
Other (Solubility) 
Water (KF) 
Brown fine powder 
Passes 
Compares to historical 
225% or 2250 ug/mg 
1.6% 
<0.1% 
Passes 
1.4% 
Purity assignment based on microbiological assay data 
with support from transfer data. 
Notes: Bottles are labeled 98162-QCS-XX, where XX represents the subdivision 
Source lot for this material is V980122. 
Prepared by: 
K. A. Sullivan 
Special Testing & Analytical Development 
/*A>\/9A 
Date 
Approved by: /? ALJ'SttLù 
f / . 
Dr. K. J. Dennis, Group Leader ' / Rate 
Special Testing & Analytical Development 
LC-MS CHARACTERISATION OF VIRGINIAMYCIN REFERENCE STANDARD AND 
COMPARISON OF VIRGINIAMYCIN M l CONTENT OF AVAILABLE VIRGINIAMYCIN 
REFERENCE STANDARDS FOR CANFAS COLLABORATIVE STUDIES 
Author: C.A.J. Hajee, RIKILT 
Date: 26 September, 2000 
INTRODUCTION 
Dr. A. Roger from Danish Plant Directorate (DPD) donated a large quantity of virginiamycin reference 
standard originating from Pfizer, lot 98162-QCS. This is designated to be used during the collaborative 
studies for virginiamycin in animal feed. The supplied analysis certificate from Pfizer, however, stated an 
expiration date of January 2000. To check the integrity of the reference standard, it was compared to two 
similar reference standards also originating from Pfizer, with a stated expiration date of January 2003. One 
of the prerequisites for the use of the reference standard from DPD is that the available standards show 
comparable responses for the marker component virginiamycin M l . 
PROCEDURE 
General 
Three vial portions of virginiamycin reference standard, labelled V2 (RIKILT), 00-012 (DPD, lot 98162-QCS) 
and 00-015 (NVI), were available for comparison. Each originated from Pfizer lot nr. 980122 with a certified 
microbiological activity of 2250 ug/mg. 
Stock solutions were prepared from each reference standard vial at -500 ug/mL in methanol. Diluted stock 
solutions at - 50 ug/mL were prepared by dilution in HPLC mobile phase. A 10-ug/mL standard solution 
was prepared by fivefold dilution of the diluted stock solution in mobile phase. 
LC-UV analysis 
Aliquots (50 uL) of the 10-ug/mL standard solutions were injected in duplicate into an LC UV system for the 
detection of virginiamycin in compound animal feeds. 
Characteristics are: 
LC column: 250 mm x 4.6 mm, Lichrospher CI8, 5 urn packing. 
Mobile phase: Acetonitrile / water / formic acid 400+600+3 (v+v+v). 
Flow rate: l.Oml/min. 
Detection wavelength: 235 nm. 
Injection volume: 50 uL. 
Analysis time: 30 min 
Specific response, i.e. virginiamycin Ml response per ug injected virginiamycin was calculated and 
compared. 
LC-MS analysis 
Aliquots (20 uL) of the 10-ug/mL 00-012 standard solution were injected in duplicate into an LC MS system. 
Identification of virginiamycin Ml was performed with MS3-detection on the basis of diagnostic ions m/z 
355, 337, 260 and 247. These fragmentations had already been identified in an earlier stage of the 
CANFAS project. 
Characteristics of the LC-MS system were: 
LC column: 250 mm x 4.6 mm, Lichrospher C18, 5 urn packing. 
Mobile phase: Acetonitrile / water / formic acid 400+600+3 (v+v+v). 
Flow rate: l.Oml/min. 
Detection wavelength: Finnigan LCQ ion-trap mass spectrometer operated standard settings 
Injection volume: 20 uL. 
Analysis time: 20 min 
MS3-detection method applied for the identification of virginiamycin Ml comprised the following settings: 
mlz = 526 I W - " . A A - « > *
 ) w / z = 508 * " •« * * • "» > m/z = [135;600] 
RESULTS 
LC-UV analysis 
Results of the LC analyses of each injected standard solution are shown in Table 1. 
Table 1. Individual responses and derived specific responses for the available virginiamycine reference 
standard vial portions. 
Injection Nominal 
volume concentration. 
Sample name 
ImU [ug/mL] 
Response Specific 
response 
[uV*s] [uV*s/ug] 
0,05 
0,05 
0,05 
0,05 
0,05 
0,05 
9,94 
9,94 
10 
10 
10,01 
10,01 
00-012 10 ug/mL 
00-012 10 ug/mL 
00-015 10 ug/mL 
00-015 10 ug/mL 
V2 10 ug/mL 
V2 10 ug/mL 
416082 
415544 
426126 
424628 
403249 
400868 
837187,1 
836104,6 
852252 
849256 
805692,3 
800935,1 
One-way analysis of variance with these data supports a hypothesis that there is no significant difference in 
virginiamycine Ml presence between the three vial portions. 
LC-MS analysis 
Results of the LC-MS3 experiment are presented in Annex 1. 
A total ion count (TIC) mass chromatogram showed a major peak at -11.25 min corresponding to 
virginiamycin M l . A mass spectrum of this peak showed fragment ions at m/z 355, 337, 247 and 260, 
which is similar as found earlier. Mass chromatograms at m/z 355, 337, 247 and 260 of the 20-uL-aliq'uot 
of the 10-ug/mL solution containing virginimycin reference standard 00-012 (DPD) all showed the major 
peak at retention time -11.25 min. Conclusion: virginiamycine Ml identity confirmed. 
\000925\std. virginiamycine 00-012 
T: 0.00- 19.99 SM: 5G 
100-
09/25/00 02:13:14 PM 
ft 
11.27 
50-
0 
100-
H 0.64 2.60 4.14 5.91 6.83 9.08 
11.38 
11.46 
v 11-72 14.05 16.27 
t%Hjt /C 
NL: 1.31E7 
TIC MS std. virginiamycine 00-012 
19.02 
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11.18 fin.42 
50-q :\ 
Î 2.51 3.22 5.13 6.38 8.63 10.71 ,.'
 v 11.66 13,42 
11.23 
3 0 
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SwluA JJVI X I T 5 5 
Antibiotics Plant 
Rue de l'Institut, 87 A 
B-1330 Rixensart, Belgium iKlSSj fUy^ tj/l/to 
Analysis nr January I99* 
Certificate of Analysis 
MAMF OF P R n m irrr • VIRGINIAMYCIN 
Reference Standard 
PRODUCT CODE : 
LOTNr: V980122 
QUANTITY : 250 mg 
^ACKED IN MANUFACTURE DATE : January 1998 
EXPIRY DATE : January 2003 
STORAGE AND USE : 
It is recommended that Virginiamycin Standard be stored at +4°C and be allowed to warm to 
room temperature prior to opening the container. 
For a period longer than 1 month : Store the vials in a freezer at -21 °C. 
Do not dry before use. 
1. DESCRIPTION Brown fine powder having a characteristic odor and 
a very bitter taste. 
2. SOLUBILITY Passes 
3. IDENTITY (HPLC) Passes 
4. LOSS ON DRYING 1.6% 
5. RESIDUE ON IGNITION 
6. VIRGINIAMYCIN 
(Microbiological assay) 
Less than 0.1 % 
225 % or 2250 mcg/mg 
üneilallfc- ^ V - • HI
 ; ^ 
Quality Assurance 
^y 
, M > 
^v°v Imh^ 
PPG/MD Quality Operations 
Analytical Resource Group 
Pfizer Ino 
Eastern Point Road 
CERTIFICATE OF ANALYSIS 
REFERENCE STANDARD 
Virginiamycin 
LOT98162-QCS 
Purity: 225% or 2250 ug/mg Virginiamycin when used as is 
Manufacture Date: January 1998 
PARAMETER RESULT 
Appearance 
H PLC - Identification 
IR - Identification 
Microbial Assay 
LOD 
Residue on Ignition 
Other (Solubility) 
Water (KF) 
Brown fine powder 
Passes 
Compares to historical 
225% or 2250 ug/mg 
1.6% 
<0.1% 
Passes 
1.4% water \r\r) i . t /o 
Purity assignment based on microbiological assay data 
with support from transfer data. 
Notes: Bottles are labeled 98162-QCS-XX, where XX represents the subdivision. 
Source lot for this material is V980122. 
Prepared by: 
Approved by: 
.^jtdnhJJu/C 
K. A. Sullivan Date 
Special Testing & Analytical Development 
/* 1*3/9? 
Dr. K. J. Dennis, Group Leader ' / Date 
Special Testing & Analytical Development 
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Table with results, questionnaire (page 1) and chromatograms 
of partner 11 
Annex 2 
CANFAS 
i Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGINIAMYCW 
Unit 
Sample code 
116856 
116884 
116891 
116899 
116918 
116922 
116943 
116946 
Result 1 
(mg/kg) 
0 
0,27 
0,63 
3,32 
0 
0 
3,83 
0 
Result 2 
(mg/kg) 
0 
0,37 
0,68 
2,87 
0 
0 
4,30 
0 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
IMzÂM^ûfmHkktÂd. ^<?. Date(s) of analysis: ..<fXMW...ZAM.....ï:.lA*k+ 
Calculations for ttw» stnrk solution (4.4.1): 
. • Amount of virginiamycin reference Standard weighed: .7.%,'ff..... mg 
. Volume of methanol: ..MP.. ml 
• Concentration of the stock solution: ..V..QCL ug microbiological activity/ml 
Chromatographie conditions: 
• Column: 
• ^As described in the method UchrOSpher CJK, JZodmrn t jf£*»t»? 
• G Other: 
• Mobile phase: 
• ) ( As described in the method 
• D Other: 
• Flowate: ...1/M........ m|/min 
• Injection volume: JW. ul 
• Retention time of virginiamycin Ml : . /<L. min 
Chromatoprarm- P l e a s e inr '"d f l representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Recovery results: 
• Percentage recovery: .••-•• % 
• Single / duplicate determinations: G single ^duplicate 
• If duplicate, please give both percentages: i L % and M . % 
• Spiking level:....!.... mg/kg rvi.a*. 
.lAS^LClO Ver.=1.63 SYS=1 REPORT.NO=39 DATA=VIR02122 .KOI 00/11/02 21:46:43 
ï j ^ l e 
3 
impie Amount 
rpe 
ï t e c t o r 
j e r a t o r 
2thod Name 
116922 om 
(11 
Unknown 
SPD-MIO. 
VIRGINIA.MET 
Chromatogram 
mAbs 
100 
'** Peak Report *** 
. ! No Identified Peak I1 3P. 
i/ 
39 - 1/2 
CLASS^ätXlO V e r . = 1 . 6 3 SYS=1 REPORT.NO=41 DATA=VIR02120 . KOI 0 0 / 1 1 / 0 2 2 0 : 2 3 : 3 0 
Sample : 1 1 6 8 9 9 om 
ID : . 
Sample Amount : 1 
Type : Unknown 
Detector : SPD-M10 
Operator : . 
Method Name •„ -. VIRGINIA.MET 
*** Chromatogram 
mAbs l 
1 0 0 
50-
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x
— ~ - ~ - % _ —^~~v 
10 20 30 40 
min 
** Peak Report *** 
^0 ChNO TIME AREA 
13 -, TIME 11.508 
MK PURITY.UP PURITY.DOWN IDNO 
1330701 0.9346(1.0000) 0.9874(1.0000) 1 
CONC 
16.5984 /SVa,-. o 2_ 
1330701 16.5984 
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Annex 2 
CANFAS 
; Development and Validation of HPLC-methods for the official control of 
jCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGINIAMYCIN 
Unit 
Sample code 
156842 
156852 
156873 
156904 
156921 
156938 
156957 
156958 
Result 1 
(mg/kg) 
blank 
blank 
0,35 
blank 
0,68 
blank 
0,57 
1,82 
Result 2 
(mg/kg) 
blank 
blank 
0,32 
blank 
0,69 
blank 
0,4 
1,68 
CÀNFAS COLLABORATIVE STUDIES OCTOBER 2 0 0 0 - VIRÖNIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis: .!£-.?. ]b.£.^ /7.£>£X .^ ZQèO 
Calculations inr the stock solution (4.4.1): 
• Amount of virginiamycin reference standard weighed: . f&iv3-/#mg 
• Volume of methanol: fe Q.... ml 
• Concentration of the stock solution:. *?.??$?.... pg microbiological activity/ml 
Chromatographic conditions: 
• Column: 
• yÙ& described in the method 
• D Other: 
• Mobile phase: 
• }s£As described in the method 
• D Other: '. 
• Flow-rate:.. .À\Q. m(/min 
• Injection volume: .<Wr?....ul 
• Retention time of virginiamycin Ml : Ax*, min 
Chromatograms: Please include representative chromatograms of; 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
BecQverv results; 
• Percentage recovery: % 
• Single / duplicate determinations: Z single ^duplicate 
• If duplicate, please give both percentages:^?.-^ % and .££.. % 
• Spiking level: . A J T . mgAg s JU.0 f**$}*\ f m . Q , . 
C a 4*-J.±:e C ï A«PC33EM \ 1 \BATA.\Ï \ VIRGO O 2 6 ; D sampxe warne: xüt>yaö 
Injection Date 
Sample Name 
Acq; Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
12/8/00 1:07:16-AM 
156938 
C:\HPCHEM\l\METHODS\MVALVIRG.M 
12/8/00 1:05:48 AM by 
(modified after loading) 
C:\HPCHEM\l\METHODS\MVALVIRG.M 
12/11/00 12:49:28 PM by 
(modified after loading) 
Seq. Line 
Vial 
inj 
Inj Volume 
26 
17 
1 
100 /il 
DAD1 A, Sig=235,50 Ref=350.80 (ADUVIRG0026.D) 
mAU 
40-
30 -
20 -
10 
0 -
-10 
10 15 
—r~ 
20 25 mir 
External Standard Report 
Cbrted By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday,- December 11, 2000 12:49:15 PM 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,50 Ref=350,80 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] [ng/ul] 
11.956 
Totals : 0.00000 
Results obtained with enhanced integrator! 
1 Warnings or Errors : 
Warning : Calibrated compound(s) not found 
Virginiamicin 
strument 1 12/11/00 12:52:03 PM Page l of 2 
àta P i l e G: \HPSlp1\l\DATA\' AVIRG0029 .D i>ampj.e »cuius ; l a o s j ' 
Injection Date 
Sangle Name 
Acq. Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
12/8/00 2:43:19 AM 
156957 
C:\HPCHEM\1\METH0DS\MYALVIRG.M 
12/8/00 2:41:52 AM by 
(modified after loading) 
C:\HPCHEM\1\METH0DS\MVALVIRG.M 
12/11/00 9:37:25 AM by 
(modified after loadinq) 
Seq. Line 
Vial 
Inj 
Inj Volume 
29 
20 
,1 
100 fil 
DAD1 A, Sfc=235,50 Ref-350,80 (ADLW1RG0029.D) 
mAU 
4(H 
30 H 
20 
10 
-10 - i 1 — — • r 
5 
- i 1 1 — 
10 15 20 
~r~ 
25 
External Standard Report 
Ported By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday, December 11, 2000 9:37:25 AM 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,50 Ref=350,80 
RetTime Type Area Amt/Area Amount Grp Name 
train] [mAU*s] , t n g / u l ] 
I I I I I - - I - - - - -
11.969 MM 163.52209 1.73966e-2 2.84472 V i r g i m a m i c i n 
t o t a l s . 2 .84472 X 0-& r £>•$ * ^ I K. (m-s~. 
^^esults obtained with enhanced integrator^ 
====== ^ ^
 E ^ d o f R e p o r t *** 
*st ^
m e n t 1 12 /11 /00 9 :58 :35 AM Page l of 1 
\ a 
a. Pile C : \HPGHEM\i\DÄTAV \VIRG0017 »D OCUUfeSJLCï *«Mt< 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
12/7/00 8:19:13 PM 
156904 
C : \HPCHEM\1 \METHODS\MVALVIRG. M 
12/7/00 8:17:47 PM by 
(modified after loading) 
C:\HPCHEM\1\METH0DS\MVALVIRG.M 
12/11/00 9:37:25 AM by 
(modified after loading) 
Seq. Line 
Vial 
Inj 
Inj Volume 
17 
14 
1 
100 /:! 
DAD1 A. Sig=235,50 Ref=350,80 (ADLAV1RG0017.D) 
mAU 
- 1 — 
10 
—1 <~ 
15 20 
— | 1 r-
25 M 
External Standard Report 
Ported By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday, December 11, 2000 9:37:25 AM 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,50 Ref=350,80 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] [ng/ul] 
11.954 
Totals : 0.00000 
Results obtained with enhanced integrator! 
1 Warnings or Errors : 
Warning : Calibrated compound(s) not found 
Virginiamicin.-
nstrument 1 12/11/00 9:43:40 AM 
Page l of 2 
a t à F i l e Gl^H^(3HEM\l\DATA\ \VIRG0014O) üarapxe JNttiue : aoo/of s 
I n j e c t i o n Date 
Sa t te le Name 
Acq. O p e r a t o r 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
12/7/00 6:43:15 PM 
156873 
C:\HPOÏEM\l\METH0DS\MVALVIRG.M 
12/7/00 6:41:48 PM by 
(modified after loading) 
C : \HPCHEM\1\METH0DS\MVALVIRG. M 
12/11/00 9:37:25 AM by 
(modified after loading) 
Seq. Line 
Vial 
Inj 
Inj Volume 
14 
11 
.1 
100 ni 
1,50 Ref=350,80 (ADLWIRG0014.D) 
™orted By 
Calib. Data Modified 
Multiplier 
Dilution 
External Standard Report 
Signal 
Monday, December 11, 2000 9:37:25 AM 
1.0000 
1.0000 
S i g n a l 1 : DAD1 A, Sig=235,50 Ref=350,80 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] Ing /u l ] 
_ |_ I | - - I | - - | - - - - - - - - - -
11.947 MM 90.19824 1 .75183e-2 1.58012 V i r g i m a m i c i n 
T o t a l s . 1.58012 xO.Zz O. 2>£ ^ ^ tm' 
R e s u l t s o b t a i n e d w i t h enhanced i n t f 9 f ^ ° f :
 = _ _ = = = 
=========-=
 # # # B n d Q f R e p 0 r t *** 
1st ^ m e n t 1 12 /11 /00 9 :38 :16 AM •• Page l of l 
)ata P i l e C:^HPtpjBM\i\UAUiÄ\ \viKwuuia /u &cun£u.<s «a iue : • i a p o ; 
Inj ectibn Date 
Satrapie Naine 
Acq. Operator 
Acq. Method 
Last changed 
: 12/7/00 6:11:14 PM Seq. Line : 
: 156852 Vial : 
inj : 
Inj Volume : 
: C:\HPCHEM\1\METHODS\MVALVIRG.M 
: 12/7/00 6:09:46 PM by 
13 
10 
.1 
100 ßl 
Analysis Method 
Last changed 
(modified after loading) 
C:\HPCHEM\l\METHODS\MVALVIRG.M 
12/11/00 9:29:14 AM by 
(modified after loading) 
DAD1 À, Sig«235.50 Ref=350,80 (ADLW1RG0013.D) 
mAU ] I 
40 -
30 
20 -
10-
0 -
-10 
10 
- r -
15 •"• ' 1 20 
- . 1 1— 
2S 
Por ted By 
Calib. Data Modified 
Multiplier 
Dilution 
External Standard Report 
Signal 
Monday, December li, 2000 9:29:14 AM 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,50 Ref=350,80 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] [ng/ul] 
11.954 
Totals : 
Virginiamicin 
0.00000 
Results obtained with enhanced integrator! 
1 Warnings or Errors : 
Warning : Calibrated compound(s) not found 
istrument 1 12/11/00 9:34:51 AM 
Page 1 of 2 
>afca F i l e C:\HPGHBM\1\DATA\ '\VÏRG0011.D 
\ _ . 
Sample Name: i5ê8Ï2 
Inj «eetion Date 
Sample Name 
Acq i- Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
12/7/00 5:07:10 PM 
156842 
C : \HPCHEM\ 1 \METH0DS \MVALVIRG. M 
12/7/00 5:05:44 PM by 
(modified after loading) 
C:\HPCHBM\1\METHODS\MVALVIRG.M 
12/11/00 9:29:14 AM by 
(modified after loading) 
Seq. Line 
Vial 
Inj 
Inj Volume 
"DÂD1 A, SJg=235,50~Ref=350,80 (ADUVIRG0011 .D) 
mAU 
«H 
30 -A 
20 H 
10 
-10 
1 1 
8 
% 1 
1 0 0 nl 
10 
—r— 
15 20 25 
External Standard Report 
Ported By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday, December 11, 2000 9:29:14 AM 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,50 Ref=350,80 
RetTime Type Area Amt/Area
 rAmount Grp Name 
[min] [mAU*s] , . fng/ul] 
11.954 
totals : 0.00000 
Results obtained with enhanced integrator! 
1
 Warnings or Errors : 
Urning : Calibrated compound(s) not found 
Virginiamicin 
i$t a n i e n t 1 1 2 / 1 1 / 0 0 9 : 2 9 : 3 6 AM Page 1 o f 2 
lata Pile CfWCHBM\1\DÄTÄ\ \VIRGÖÖ30.D Sattle NaÉèVlilll8 
12/8/00 3:15:20 AM Seq. Line : 30 V—^ 
156958 Vial : 21 
Inj : '1 
Inj Volume : 100 /il 
C:\HPCHEM\l\METHODS\MVALVIRG.M 
12/8/00 3:13:52 AM by 
(modified after loading) 
Analysis Method : C:\HPCHEM\l\METHODS\MVALVIRG.M 
12/11/00 10:22:48 AM by 
(modified after loadinq) 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Last changed 
Last changed 
DAOI A, Sig=235,50 Ref=350,80 (ADLW1RG0030.D) 
mAU 
i 
4 0 -
30 
2 0 -
10-
-10 
10 
- T — 
15 20 25 JQI 
External Standard Report 
^Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday, December il, 2000 8-59-41 AM 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,50 Ref=350,80 
RetTime Type Area Amt/Area Amount Grp Name 
tmin] [mAU*s] [ng/ul] 
487.27155 1.72971e-2 8.42839 Virginiamicir, ' 
8.42839 x O.Sj s. A.é ? ^  / ^ L /*»•»-
11.972 MM 
Totals : 
Results obtained with enhanced integrator! 
*** End of Report *** 
strument 1 12/11/00 10:23:19 AM 
Page l of l 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 21 
Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official cc 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-C1 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Date of analysis: 
Analyte: \_ VIROINIAWYCIN 
Unit 
Result 1 
(mg/kg) 
Sample code 
216853 
216863 
216875 
216879 
216892 
216894 
216919 
216925 
0,0 N.D. 
0,0 N.D. 
1.4 
0.4 
0,0 N.D. 
0.4 
0,0 N.D, 
2,4 
Result 2 
(mg/kg) 
0,0 N.D. 
0,0 N.D. 
..1.4 
0,5 
0,0 N.D. 
0,6 
0,0 N.D. 
2,2 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysi: s: .AÀ\S\$$$...*xd JÄIM^., 
Calculations for the stock solution (4.4.1): 
• Amount of virginiamycin reference standard weighed: 'Wf^k^. mg 
• Volume of methanol:... >?.Q..... ml 
• Concentration of the stock solution: ~l.!.?/.^?. ug microbiological activity/ml 
Chromatographic conditions: 
• Column: 
• G As described in the method . 
. D Other: .£Ç.M..S«pïïÇ&$~l *$.^...*.fljc£.&<?±JS^!:GU^ ö Li 
• Mobile phase: 
• J r f e described in the method 
• D Other: 
• Flow-rate:..../£:. ml/min 
• Injection volume: .Jm2..\i\ Jr\s\ 
• Retention time of virginiamycin Ml : .....vn min 
Chromatngrams- Please incurie representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
fees-very results; 
• Percentage recovery: *?.Vr% 
• Single / duplicate determinations: D single ^duplicate 
' If duplicate, please give both percentages: &f t . % and .£>.... % 
• Spiking level: .fyD.. mg/kg 
C : \HPCHEM\2 \CR0MAT\VIRG3 \863 -A. D Sample Name: 863-A 
>^tion Date 
>4ple Name 
/fcq. Operator 
Acq. Method 
Last changed 
: 06/12/2000 3.07.39 
: 863-A 
: C:\HPCHEM\2\. \VIRGT 
: 06/12/2000 3.05.50 
Seq. Line : 19 
Vial : 14 
Inj : 1 
Inj Volume : 100 /il 
.M 
Analysis Method 
Last changed 
(modified after loading) 
C:\HPCHEM\2V . \VIRQ 
06/12/2000 10.44.05 
(modified after loading) 
M 
DAD1 A, Sig=235,8 Ref=off (VIRG3\863-A.D) 
mAU 
100-
8 0 -
60 
40 
2 0 -
~r~ 
10 
- 1 — ' — • -
15 
I 
20 I 25 -. , p-30 jm 
External Standard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
06/12/2000 10.11.29 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,8 Ref^off 
RetTime Type 
[min] 
Area 
[mAU*s] 
Amt/Area Amount 
[ng/inj] Grp Name 
1-1 10.096 
Totals : 0.00000 
Results obtained with enhanced integrator! 
1 Warnings or Errors : 
VlRG-virginiamicin 
Warning : Calibrated compound(s) not found 
afca Pile C:\HPCHEM\2\CROMAT\VIRG3\875A.D it^ a sampie warne : O O H 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
DAD1 A, Sig=235,8 Ref=off (V1RG3\S75A.D) 
05/12/2000 17.14.12 
875A 
C : \HPCHEM\2 \. \VIRG' 
05/12/2000 17.12.22 
(modified after loading) 
C:\HPCHEM\2\ \VIRG 
06/12/2000 10.44.05 
(modified after loading) 
.M 
M 
Seq. Line 
Via l 
i n j 
In j Volume 
3 
2 
1 
1 0 0 fil 
mAU 
100 H 
80 
«H 
40H 
20 
—, , r-
10 
- 1 — ' — " -
15 ~r-20 
—r-
25 30 mlrl 
External Standard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
06/12/2000 10.11.29 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,8 Ref-off 
RetTime Type Area Amt/Area Amount 
[min] [mAU*s] tng/inD] 
Grp Name 
576.18176 10.055 MM 
Totals : 
Results obtained with enhanced integrator! 
1.19295 687.35580 VIRG-virginiamicin 
687.35580 
l
°äe imitf ne/i 5/2000 10.44.06 Page l of 2 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 22 
Annex 2 
CANFAS 
! Development and Validation of HPLC-methods for the official control of 
IÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGIN IAMYCÏN 
Unit 
Sample code 
226840 
226858 
226882 
226887 
226890 
226913 
226926 
226951 
Result 1 
(mg/kg) 
<0.5 
1
-
24 
<0.5 
1,42 
<0.5 
0,55 
<0.5 
0,58 
Result 2 
(mg/kg) 
<0.5 
1,31 
<0.5 
1,71 
<0.5 
0,53 
<0.5 
0,54 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis: .SfiJ.!....l.5....//...(?.Ç..l!..2.?:. 
Calr.riatinns for ttiP stock solution (4.4,1); 
• Amount of virginiamycin reference standard weighed: ..W.\. w. . mg 
• Volume of methanol: . . î ^ tS m l ^ 
• Concentration of the stock solution:SSîf^î"ug microbiological activity/ml \}.' c^»«u o * * * c * \ H I 
C ß e - k ^ - W i COiA+CU*«, Ç > ( ^ * / a VlWw^Wuü'H H l ] 
Chromatography conditions^ 3 T J ^ " ' > 
• Column: 
. G As described in the method ft u p e r s i I ©ÖS fcOS O §
 f 2 £ D *wvn x ^ 6 ^ S^ 
• D Other: 
• Mobile phase: 
• V A S described in the method 
• a Other: >•'• 
• Flow-rate: . . . Ö t & m|/min 
• Injection volume: .AM....ul 
• Retention time of virginiamycin Ml :. I. !.... min 
Chrnmatograimr P'a a s a i n c ' l l f f » representative chromatQErams of; 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Becovery results; _ 
• Percentage recovery: Ö.W.. % 
• Single / duplicate determinations: G single ^ duplicate 
• If duplicate, please give both percentages: J & % and . . t f l . % 
• Spiking level:'...U-»- m ^ 
( & 
NEW TIMED EVENTS FROM VIRGINIA 
******* EXTERNAL STANDARD TABLE ******* 
******************** n_-9Q-?nnn n .10 . 1^ 7 yórei ^ n 5.1 ********************** 
* Sample Name: prov 1 \Sa**plC Z2fcfeH0l Data File: D:vira04 9 
* Date: 11-14-2000 21 :3b :4bMethod: VIRGINIA 11-29-2000 13:16:52 # 672 * 
* Interface: 0 Cycle#: 1 Operator ann Channel#: 0 Vial#: * 
* Starting Peak Width: 50 Threshold: .05 Area Threshold: 50 * 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** ************************************ 
S t a r t i n g D e l a y : 
Area r e j e c t : 
Amount i n j e c t e d : 
Sample Weight : 
PEAK RET PEAK 
NDM TIME NAME 
1 1 1 . 5 1 1 
TOTAL AMOUNT 
0 . 0 0 
50 
80 . 0 0 
1 . 0 0 0 0 0 
CONCENTRATION i n 
ug/ml 
0 . 0 6 9 1 
0 . 0 6 9 1 
NORMALIZED 
CONC 
100.0000% 
AREA 
5528B 
Ending r e t e n t i o n 
One sample p e r 
D i l u t i o n f a c t o r : 
AREA/ REF 
HEIGHT HEIGHT BL PEAK 
1056 5 2 . 4 1 
t i m e : 4 5 . 0 0 
0 . 2 0 0 s e c . 
1 . 0 0 
t DELTA 
RET TIME CONC/ARBA 
1.2500E-06 
PEAKS NOT FOUND IN THIS RUN 
Î0IE ADJUSTED RET. TIME. REFERENCE PEAK 
virgin 10.83 virgin 
Data File = D:virg049.PTS Printed on 11-29-2000 at 13:33:00 
Start time: 0.00 min. Stop time: 20.00 min. Offset: 0 mv. 
Low Value: 0 uv High Value: %233 973 9 uv Scale factor: 8.0 
******* EXTERNAL STANDARD TABLE ******* 
******************** n-i*-?nnn m;32;47 Version 5.1 ********************** 
* Samole Name- prov 2' f Sd*vp'<* Z2-fegSgJ Data File: D:VIRG050 
* Date 11-14-2000 22:23 :4 6Method: DTVIRGINIA 11-15-2000 10:32:35 # 610* 
* Interface- 0 Cycle#: 1 Operator ann Channel#: 0 Vial#: * 
* Qtartina Peak Width: 10 Threshold: 1 Area Threshold: 100 * 
j + ^ + + lMMk.******************************************************* 
Starting Delay: 0.00 " Ending retention time: 30.00 
Area reject: 100 One sample per 0.200 sec 
amount injected: 80.00 Dilution factor: 1.00 
Sample Weight: 1.00000 
PEAK RET 
NOM TIME 
1 8.261 
2 8.948 
3 10.054 
4 10.837 
5 12.154 
PEAK 
NAME 
virgin 
TOTAL AMOONT 
CONCENTRATION in 
ug/ml 
0.1085 
0.0852 
0.0263 
6.2784 
0.0167 
6.5151 
NORMALIZED 
CONC 
1.6653% 
1.3084% 
0.4036% 
96.3658% 
0.2569% 
AREA 
86799 
68195 
21035 
609134 
13388 
AREA/ 
HEIGHT HEIGHT BL 
5837 
2157 
1183 
34936 
775 
14.9 2 
31.6 2 
17.8 1 
17.4 1 
17.3 1 
REF 
PEAK 
4 
% DELTA 
RET TIME 
0 
CONC/AREJ 
1.2S00E-C 
1.2500E-1 
1.2500E-I 
1.0307E-C 
1.2500E-( 
D:VIRGO50.ATB ar--- f-impg and heights stored in: 
S a FiÏÎ - D-5ÎRG050 PTS Printed on 11-15-2000 at 10:32:49 
Start time: * 0.00 min. Stop time: 20 00 mi; 
k)w Value: 0 uv High Value: «2574000 uv 
Offset: 0 mv. 
Scale factor: 8.0 
zy 
******* EXTERNAL STANDARD TABLE ******* 
******************** 11-15-2000 J-Q: 33:33 V e r s i o n 5 . 1 ********************** 
*' Sample Name: p r o v 6 | S tumble Z.ZfeS \*?T) Da ta F i l e : D:VIRG054 
* Date: 11-15-2000 01 HlTsiMethod: D:VIRGINIA 11-15-2000 10:32:35 # 610* 
* Interface : 0 Cycle#: 1 Operator arm Channel*: 0 Vial#: * 
* Starting Peak Width: 10 Threshold: 1 Area Threshold: 100 * 
*************************************************************************** S t a r t i n g D e l a y : 
Area r e j e c t : 
Amount i n j e c t e d : 
Sample Weight : 
PEAK RET 
NOM TIME 
1 8:471 
2 9 .251 
3 10 .376 
4 10 .844 
5 1 1 . 8 5 1 
6 12 .749 
• 
PEAK 
NAME 
virg in 
TOTAL AMOUNT 
0.00 
100 
8 0 . 0 0 
1 .00000 
CONCENTRATION i n 
m 
ug/ml 
0 . 0 9 7 0 
0 . 4 9 6 2 
0 . 0 2 1 6 
2 . 8 1 6 8 
0 . 0 9 3 9 
0 . 0 3 8 3 
3 . 5 6 3 7 
NORMALIZED 
CONC 
2.7220% 
13.9247% 
0.6055% 
79.0398% 
2.6335% 
1.0745% 
AREA 
77605 
396993 
17264 
273287 
75081 
30634 
Ending r e t e n t i o n 
One sample p e r 
D i l u t i o n f a c t o r : 
AREA/ 
HEIGHT HEIGHT BL 
5439 
19763 
969 
14870 
4437 
2065 
1 4 . 3 1 
2 0 . 1 1 
1 7 . 8 2 
1 8 . 4 2 
1 6 . 9 1 
1 4 . 8 1 
REF 
PEAK 
4 
t i m e : 3 0 .00 
0 .200 s e c . 
1.00 
% DELTA 
RET TIME 
0 
CONC/AREA 
1.2500E-06 
1 .2S00E-06 
1.2S00E-06 
1 .0307E-05 
1.2500E-06 
1 .2500E-06 
Areas, times, and heights stored in: D:VIRG054.ATB 
Data File = D:VIRG054.PTS Printed on 11-15-2000 at 10:33:35 
Start time: 0.0 0 min. Stop time: 20.00 min. Offset: 0 mv. 
Low Value: 0 uv High Value: %2591782 uv Scale factor: 8.0 
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Annex 2 
CANFAS 
iDevelopment and Validation of HPLC-methods for the official control of 
iCoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGINIAMYCIN 
Unit 
Sample code 
256850 
256861 
256898 
256908 
256914 
256931 
256941 
256955 
Result 1 
(mg/kg) 
0 2 r * 
nd* 
nd* 
nd 
nd 
0,22** 
0,51 
0,73 
Result 2 
(mg/kg) 
0,21** 
nd* 
nd* 
nd 
nd 
0,22** 
0,58 
0,70 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis: fer&r.&S??. 
Calculations for the stock solution (4.4.1); 
• Amount of virginiamycin reference standard weighed:... ~? mg 
• Volume of methanol: ..?£y.5 ml 
• Concentration of the stock solution:..59Q.... pg microbiological activity/ml 
Chromatographic conditions: 
• Column: 
• HT As described in the method 
• D Other: 
• Mobile phase: 
• a As described in the method 
. « Other: Hi.*....<?.£JK£tfHAXtiÙtéyYUNM&.WS.fc*?*K»*£\&. * £ q .
 M $50\.5£v+-v+-
• Flow-rate: . . . . 1 . ml/min 
• Injection volume: ...ko...pi 
• Retention time of virginiamycin Ml: .£,£& min 
Chromatograms; Please include representative chromatQgrams of; 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Recovery results: 
• Percentage recovery: $?.... % 
• Single / duplicate determinations: % single a duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: ...\.0..... mg/kg 
O! 
U 
' C 
m 
X> 
o 
e 
XI 
<x 
o 
o 
ir» 
o 
O 
s w 4 zséîéi 
0.0000 0.0600 
0.0200 
A b s o r b a n c e 
0.0400 
-i i } i 
0.0600 
S&AvJjls Z^hijB 
- 0.0000 
0.00 
Absorbance 
0.0200 ' 
i _J 
0.0400 0.0600 
J_l_ 
i=——;> 2.17 
: T2.66ï 2.77 
. 3.26;[3.39 
; 3.70; 3.941 
4.08 ' 
4.49 
T r 
0.0200 
A b s o r b a n c e 
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Annex 2 
CANFAS 
! Development and Validation of HPLC-methods for the official control of 
IÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
* • • • - • • > • . . . . . . . . r 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
I VIRGINIAMYCIN 
Unit 
Sample code 
266833 
266848 
266855 
266869 
266893 
266912 
266939 
266950 
Result 1 
(mg/kg) 
0,3 
3 
0,3 
2,7 
1,3 
0,3 
0,4 
1,3 
Result 2 
(mg/kg) 
0,2 
3,9 
0,3 
3 
1.1 
0,2 
0,3 
1,1 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis: 3.}>M QQ. 
Caln.latinns fnr thp stnrk SOllltion (4.4.1):
 w{°'^^ 
• Amount of virginiamycin reference standard weighed: *k..WSftmg 
• Volume of methanol:. fy&. .Q.... ml 
• Concentration of the stock solution: ..5.O.... ug microbiological activity/ml 
Chromatographic conditions; 
• Column: 
• a As described in the method 
. o Other: * «teS/AflS& £&£...?. 
Mobile phase: 
• it^As described in the method 
• D Other: • 
• Flow-rate: /.'..P.... ml/min 
• Injection volume: .sî.Ô....ul 
• Retention time of virginiamycin Ml: .».-.3 min 
rhrnmatnpramr ?\°K* ^"àe representative chromatograms oft 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Recovery results 
• Percentage recovery: #M. % •A
Single/duplicate determinations: D single ^duplicate 
If duplicate, please give both percentages: I f % and te. % 
Spiking level: ..ht.... mgAg 
~^^ç0<Ts^ (3) Software Version: 4.1<2F12> 
Date: 11/12/00 19:56 
Sample Name : A3009155A 
Data File : C:\TC4\CANFAS\VIRGINIA\REINJ\DATA017.RAW Date: 11/12/00 19:40 
Sequence File: C:\TC4\CANFAS\VIRGINIA\VIRGINI2.SEQ Cycle: 17 Channel : B 
Instrument : BOXJD Rack/Vial: 0/0 Operator: 
Sample Amount : 1.0000 Dilution Factor : 1.00 
900-EJ 
80O-3 
7 0 0 - 3 
6 0 0 - 3 
> £ 
Qî 
01 
c o 
a. m 
V OC 
5 0 0 - = 
"*^ 1 
4 0 0 - = 
30O-Ë 
2 0 0 - E 
1 0 0 - = 
=8 i 
•«t- o 
ai a i 
I l II I 
in 
CM 
T T o o 
o 
q 
T 
i T i i r m r 
a. 
I 
i i i—rr 
2 < 
i i i i | [ i i i | i i i i | i i i i i M M | i i i i | i i i i | i i i i | i i i r | i i i i | i i i i | i i i i | i M i | i i i i | i i i i | i r r r 
1
 2 4 6 8 10 12 14 
Time [min] 
Virginiamycin in Feeds Report 
Peak Time 
# [min] 
Component 
Name 
Area Height BL Area/Height 
[uV-s] [uV] [s] 
8.898 Virginiamycin 11596.50 1241.90 *BB 
11596.50 1241.90 
9.34 
-z&c&^F 
Software Version: 4.1<2F12> 
Date: 11/12/00 21:08 ( & 
Sample Name 
Data File 
Sequence File 
Instrument 
Sample Amount 
A3009156A 
C:\TC4\CANFAS\VIRGINIA\REINJ\DATA021.RAW Date: 11/12/00 20:52 
C:\TC4\CANFASWIRGINIA\VIRGINI2.SEQ Cycle: 21 Channel : B 
BOX_0 Rack/Vial: 0/0 Operator: 
: 1.0000 Dilution Factor : 1.00 
o> O) 
•*• en 
ro O 
•*• CO O l 
ci 
Time [min] 
Virginiamycin in Feeds Report 
*
eak Time 
* [min] 
Component 
Name 
Area Height BL Area /He igh t 
[uV-s] [uV] [s] 
8.994 Virginiamycin 701200.50 47649.47 *BB 14.72 
701200.50 47649.47 
/ v ?GQt?SsS 
1% Software Version: 4.1<2F12> Date: 11/12/00 22:20 
Sample Name : A3009157A 
Data File : C:\TC4\CANFAS\VIRGINIA\REINJ\DATA025.RAW Date: 11/12/00 22:03 
Sequence File: C:\TC4\CANFAS\VIRGINIA\VIRGINI2.SEQ Cycle: 25 Channel : B 
Instrument : BOXJD Rack/Vial: 0/0 Operator: 
Sample Amount : 1.0000 Dilution Factor : 1.00 
> 
E 
c o 
CL 
9 0 0 - = 
80O-Ë 
7 0 0 - = 
6 0 0 - | | 
5 0 0 - = 
<D 400 
CC ^"" — I 
300-= 
200-= 
1 0 0 - = 
m 
r» 
• * 
00 
I 
•o 
en 
T 
co o 
* p» 
a> en 
! I 
co co 
fo r-
o o 
T T 
.— co 
,— 
T 
m 
a> 
tsi 
T 
1—r~r 
2 < 
Z 
ÇÇ 
> 
I | I I ! I j MM 
4 6 8 
Time [min] 
TT TT 
10 12 14 
Virginiamycin in Feeds Report 
Peak Time 
# [min] 
Component 
Name 
Area Height BL Area /Heigh t 
[uV-s] [uV] [s] 
8.933 Virgin iamycin 22924.00 2077.60 *BB 11.03 
22924.00 2077.60 
Software Vers ion : 4.1<2F12> 
Date: 12 /12/00 02:31 
Sample Name 
Data F i l e 
Sequence F i l e 
Ins t rument 
Sample Amount 
A3009159A 
C:\TC4\CANFAS\VIRGINIA\REINJ\DATA039.RAW Date: 12/12/00 ••02:1! 
C:\TC4\CANFAS\VIRGINIAWIRGINI2.SEQ Cycle : 39 Channel : B 
BOX_0 Rack/Vial : 0/0 Opera tor : 
: 1.0000 Di lu t ion Fac tor : 1.00 
9 0 0 - 3 
8 0 0 - 3 
7 0 0 - 3 
6 0 0 - 3 
j> 500-3 ] 
c o a 
300-E 
200-3 
100-= 
Q. 
I 
m r-
.- m 
i i 
t 
q 
I 
r» 
a> * CN 
* « ! d 
?? T 
n 
oo d 
T 
i - ^ — 
05 CM 
—'t"-j 
TT 
•<* • 
en 
c\i 
T 
r
^nr--T-T-T—T—T-nTT-TT 
a. 
i 
< 
z 
o 
> 
i | | | ITTTTI I I I I I I I M 11 I I M J I M I I I I I I 111 I I I I M 11 
A. 6 8 10 
Time [min] 
TTTTTT 
12 
TTTTTTT 
14 
Virginiamycin in Feeds Report 
peak Time Component 
I [min] N ^ e 
Area Height BL Area /He igh t 
[uV-s] [uV] [s] 
3 9.036 Virginiamycin 277133.50 19228.78 *BB 14.41 
277133.50 19228.78 
'Z&C^iZ-
Software Version: 4.1<2F12> 
Date: 12/12/00 03:43 
Sample Name 
Data File 
Sequence File 
Instrument 
Sample Amount 
A3009160A 
C:\TC4\CANFAS\VIRGINIA\REINJ\DATA043.RAW Date: 12/12/00 03:27 
C:\TC4\CANFAS\VIRGINIA\VIRGINI2.SEQ Cycle: 43 Channel : B 
BOX_0 Rack/Vial: 0/0 Operator: 
: 1.0000 Dilution Factor : 1.00 
> 
E 
c o o. 
900-= 
800-§Ë 
700-= 
600-ËË 
50O-ËÊ 
| 400-=3 
300-= 
200 -= 
TT 
-nj 
en 
en 
1 
ID 
in 
co 
1 
in 
a> 
T 
CNO 
in co 
enen 
1 1 
r^ 
CM 
O 
T 
IC 
co 
o' 
T 
co (O 
en csj 
« - CN 
TT 
tO 
en 
f-j 
T 
" i~ i~n i—i—r"—T T i—n 
o 
> TT i 1 | I I M | 1 M l | I M I | i I I I j I M i [ I 1 1 1 | 1 M I | i M l | 1 1 1 1 ' 
Time [min] 10 12 
TTTTTTT 
14 
rn 
Virginiamycin in Feeds Report 
Peak Time 
# [min] 
Component 
Name 
Area Height BL Area /He igh t 
[uV-s] [uV] [s] 
8.954 Virginiamycin 27802.50 2313.17 *BB 12.02 
» — — — — . — . « . « » . * « « . • . » • • — — — — — — — — ™ — — —•—• — ^ — — — -
27802.50 2313.17 
2é£93<? 
Software Version: 4.1<2F12> 
Date: 12/12/00 04:55 
Sample Name 
< • 
Data File 
Sequence File 
Instrument 
Sample Amount 
A3009161A 
C:\TC4\CANFAS\VIRGINIA\REINJ\DATA047.RAW Date: 12/12/00 
C:\TC4\CANFASWIRGINIA\VIRGINI2.SEQ Cycle: 47 Channel 
BOX_0 Rack/Vial : 0/0 Opera tor : 
: 1.0000 Di lu t ion Fac tor : 1.00 
04:2 
B 
9 0 0 - = 
800-Ëj 
700-ÊË 
6 0 0 - = 
«> 5 0 0 - = 
W — 
I ~= 
ig 4 0 0 - E 
3 0 0 - = 
2 0 0 - = 1 0 0 - = 
Q. 
I 
cn 
o> 
I 
o> r~ 
m en 
o>>- csi oo 
" W o o 
CTIOi . - — 
I I I I 
Z 
O 
a: 
> 
»J- CM 
O) CM 
—' Cvi 
T T 
1 I 1 I I I i 1 I I . M I I M I ! I M 1 I I I I M j I I M j I M I | I I 1 I j 1 I I I j I I I | M M | I I I I I I I | | I M I t ' ) 1 1 I 
' 2 4 6 , . » 10 12 ' 14 ' 
Time [min] 
Virginiamycin in Feeds Report 
*
eak Time 
# [min] 
Component 
Name 
Area Height BL Area/Height 
[uV-s] fuV] [s] 
8.969 Virginiamycin 34049.50 2927.05 *BB 11.63 
34049.50 2927.05 
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H PLC-UV - i 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis:., .ft.0. -&\\.4t.l.Q±. 
Calculations far thp stock solution (4.4.11: 
• Amount of virginiamycin reference standard weighed: ....<&#.... mg 
• Volume of methanol: fi5..... ml 
• Concentration of the stock solution: ...5.09... ug microbiological activity/ml 
Chromatographic conditions: 
• Column: 
• Ç^  As described in the method 
• o Other: 
• Mobile phase: 
• ^ As described in the method 
• D Other: 
• Flow-rate: .ik ml/min 
• Injection volume: ..<£#ß..ul
 t ^tr 
• Retention time of virginiamycin Ml: vjdtbmin ~* 4* <£*&> 
Phromatoerams: Please include representative chromatograms of; 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Pprnvprv results: 
• Percentage recovery: % 
• Single / duplicate determinations: G single ß duplicate 
• If duplicate, please give both percentages: $%}>% and 5%.fl% 
• Spiking level: k\.... mg/kg 
Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and ^ t i b i o t i c s used a s _ £ ^ (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: )20~24/ii/oo | 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGWIAMYCIN 
— 
Unit 
Sample code 
286832 
286834 
286886 
286888 
286909 
286911 
286935 
286954 
Result 1 
(mg/kg) 
1,81 
<LOD 
0,7 
<LOD 
0,68 
<LOD 
1,51 
around LOD* 
Result 2 
(mg/kg) 
0,91 
<LOD 
0,43 
<LOD 
0,64 
<LOD 
1,73 
<LOD 
* the limit of detection (LOD) is estimated at 0,12 mg/kg 
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Annex 2 
CANFAS 
! Development and Validation of HPLC-methods for the official control of 
•Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGINIAMYCIN 
Unit 
Sample code 
296857 
296867 
296876 
296878 
296900 
296910 
296937 
296949 
Result 1 
(mg/kg) 
0,822 
0 
0 
0,224 
0,834 
0,906 
0 
0 
Result 2 
(mg/kg) 
0,709 
0 
0 
0,171 
1,141 
1,035 
0 
0 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis: . . . . « s ^ . . . M ^ ^ ? t ^ j r . . . . ^ Q ^ Q -
Calculating for the stock solution f4.4.1): 
• Amount of virginiamycin reference standard weighed: .Jfó>,.Q„ mg 
• Volume of methanol: .*?w?,fc>â. ml 
• Concentration of the stock solution: .S>^Q. ug microbiological activity/ml 
Chromatographic renditions: 
• Column: 
• D As described in the method 
• Mobile phase: • 
• B As described in the method 
• o Other: 
• Flow-rate:. .\14 •«? ml/hun 
• Injection volume: a & Q . u l 
• Retention time of virginiamycin Ml : .fw,0. min/ ct, \ * W i\ 
Chromatogr?rP*- p ' e a s e hiclude representative chromatof rams ^ft 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Recovery results: 
• Percentage recovery: % 
• Single / duplicate determinations: D single K duplicate 
• tf duplicate, please give both percentages: 5 ^ - % and .&t% 
• Spiking level: ...tfr.... mg/kg 
Virginiamycin repor 
296857 .£ -
Vial: 10 
Injection # 1 
Injection volume 100,00 ul 
Sample running time 25,0 Minutes 
Report 
"Sample Set": 
"Method Set": 
Canal: 
Project Virginiamic 
Virginiamicin 
Virginiamicirv 
PDA 235,0 nm 
Chromatogram 
0.2a 
5 
-0,02-L-'—' 
4.00 
-)—i—i—i—|—i—i—'—|—:—i—i—|—i—i—i—|—i—i—i—|—i—i—i—|—i—i—r 
8.00 10,00 12,00 14,00 16,00 18,00 20,00 22,00 24,00 
A*nutes 
1 
Compound 
Virgirteirtcir, 
RT 
9,144 
Area 
329025 
Height 
18153 
Concentration 
2,042 
Unts 
ug/rrl 
Amount of Virginiamycin in sample (mg/kg): O. S > 2 0 v ^ - / K« 
Report 
Wginiamycin report 
Project Virginiamicin 
«900 4r 
*
 1 4 
sction $ 
BCtion volume 100,00 ui 
»nple running time 25,0 Minutes 
0,2a 
3 
< 
"Sample Set": 
"Method Set": 
Canal: 
Chromatogram 
Viiginiamicins 
Virginiamicin 
PDA 235,0 nm 
Amount ofVirginiamycin in sample (mgflcg): Ax **%/*%• 
Virginiamycin report 
296949 4r 
Vial: 1 7 
Injection # 1 
Injection volume 100,00 ui 
Sample running time 25,0 Minutes 
Report 
"Sample Set": 
"Method Set": 
Canal: 
Project' Virginiamicir 
Virginiamicir 
Virginiamicirc 
PDA 235,0 nm 
Chroma togram 
3 
-]—i—i—i—i—i—i—i—r 
10,00 12,00 14,00 
Mn utes 
i — p — i — i — i — i — i — i — i — i — | — i — i — i — | — i — i — r — p 
16.00 18,00 20,00 22,00 24,00 
1 
Conpound RT 
Virginiarricir ! 9,013 
Area Height Concentration unas 
Amount of Virginiamycin in sample (mg/kg): 
Virgin ia mycin repor 
296876 <-
Vial: 12 
Injection # 1 
Injection volume 100,00 ui 
Sample running time 25,0 Minutes 
Report 
"Sample Set": 
"Method Set": 
Canal: 
Projectf Virginiamich 
Virginiamicin' 
Virginiamicin 
PDA 235,0 nm 
< 
0 3 > 
0,18"; 
0,16; 
0,14-
0,12; 
0,10; 
0,0»; 
0,06; 
0,04-
0,02-
0,00-
-0,02- • ' I' r 
2,00 
Chromatogram 
, , i i - — i — i — i — i — r — i — i — i — i — | — ' ' ' l • 
^y^VoO 8.00 10.00 12,00 14,00 
' Mnules 
~T - i — i — i — i — i — | — r -
16,00 18,00 20.00 22,00 24.0C 
QxTpound 
Vinjiniarricirv 
RT 
9,013 
Area Height Concentration Unis 
Amount of Virginiamycin in sample (mg/kg): 
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Table with results, questionnaire (page 1) and chromatograms 
of partner 31 
Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGJMIAMYCIW 
Unit 
Sample code 
316838 
316843 
316872 
316874 
316897 
316932 
316940 
316942 
Result 1 
(mg/kg) 
2,28 
<0,5 
<0,5 
0,63 
<0,5 
1,33 
<0,5 
2,91 
Result 2 
(mg/kg) 
2,66 
<0,5 
<0,5 
0,61 
<0,5 
0,68 
<0,5 
2,24 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis: (#.-...k?.r.....,&wX2. 
• 
• 
Calculations for the stock solution f4.4.H: 
Amount of virginiamycin reference standard weighed: ..$.{/..... mg 
Volume of methanol: ..4f,.2. ml 
Concentration of the stock solution: .{tffâ.... Pß microbiological activity/ml 
Chrnmatmrwhic, conditions; 
• Column: 
• KAs described in the method 
• D Other: 
• Mobile phase: 
• fe^As described in the method 
• D Other: 
• Row-rate: ....lrtf. m(/min 
• Injection volume: ...S*?..."' 
• Retention time of virginiamycin Ml : . M,fe>. min 
Chromatogrgp*- Please Include representative chromatopram^
 ftf; 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate fie virginiamycin Ml peak with an arrow 
Recovery results: 
• Percentage recovery: .4ft.. % 
• Single/duplicate determinations: D single D duplicate 
• ff duplicate, please give both percentages: % and 96 
• Spiking level: .1 r. IrM? mg/kg 
<S4> % v x ^ VS / - . 
'fv<rj>(lW^ I 
s
—Page 1 c 
Software Version 
Operator 
Sample Number 
AutoSampler 
Instalment Name 
Interface Serial # 
Delay Time 
Sampling Rate 
Volume Injected 
Sample Amount 
Data Acquisition Time 
: 6.1.1.0.0:K20 
: 007 
: NONE 
: LC-5 
: NONE 
: 0.00 min 
: 1.0000 pts/s 
: 1.000000 uL 
: 1.0000 
: 10/18/00 9:39:39 PM 
Date 
Sample Name 
Study 
RackA/ial 
Channel 
A/D mV Range 
End Time 
Area Reject 
Dilution Factor 
Cycle 
: 10/19/00 10:48:07 AM 
: 21039 
: 71.311.40 
: 0/0 
: A 
: 2000 
: 30.00 min 
500.000000 
1.00 
14 
Raw Data File : V».
 /004S\TCDATA\NRC SSM\CANFAS Virg\001018\001018_014.raw 
Result File : V ' X)04s\TCdata\NRC SSM\CANFAS Virg\001018\001018_014.rst 
Inst Method : \. t)04s\TCdata\nrc ssrmcanfas virg\001018\001018 from V. ;004s\TCdata\NRC SSM\CANFAS 
Virg\001018\001018_014.rst 
Proc Method : V, ,t)04s\TCdata\nrt; ssm\canfas virg\001018\001018.mth 
Calib Method : W ,004s\TCdata\nrc ssrmcanfas virg\001018\001018.mth 
Sequence File : \, JD04s\TCdata\NRC SSM\CANFAS Virg\001018\001018.seq 
J 
8 0 - = 
? = 
£ 6 0 - = 
S _= 
fi „ = 
o , 
CC = 
20-=. J 
S 
> 
2 4 6 B 10 12 14 16 18 
Time [mlnj 
Quantitation results 
20 22 24 
iiiiiiiiiiiiiiiim 
26 28 
Peak Ret Time Delta RT Component name Area Height Amount BL 0 [min] [%] [uVsec] [uV] [mg/kgj 
1 11.655 
2 12.362 
3 15.704 
0.0449 Virg M1 465974 23206 
72669 4244 
49194 2305 
12 BB 
0 BB 
0 BB 
Software Version 
Operator 
Sample Number 
AutoSampler 
Instrument Name 
Interface Serial # 
Delay Time 
Sampling Rate 
Volume Injected 
Sample Amount 
Data Acquisition Time 
: 61 1.0.0.-K20 
: OOö 
: NONE 
: LC-5 
: NONE 
0.00 min 
1.0000 pts/s 
LOOOOOOML 
1.0000 
10/18/00 10:10:25 PM 
Page 1 of 
Date 
Sample Name 
Study 
Rack/Vial 
Channel 
A/D mV Range 
End Time 
Area Reject 
Dilution Factor 
Cycle 
: 10/19/00 10:48:08 AM 
: 21040 
: 71.311.40 
0/0 
A 
2000 
30.00 min 
500.000000 
1.00 
15 
Raw Data File : W ..i)04S\TCDATA\NRC SSM\CANFAS Virg\001018\001018_015.raw 
Result File : \WD04s\TCdata\NRC SSM\CANFAS Virg\001018\001018 015.rst 
'nst Method : \ , ,004s\TCdata\nrc ssm\canfas virg\001018\001018 from V ;004s\TCdata\NRC SSM\CANFAS 
Virg\001018\001018 015.rst 
proc Method : \
 >*004s\TCdata\nrc ssm\canfas virgV001018\001018.mth 
Calib Method : \ l . i04s\TCdata\nrc ssirAcanfas virg\001018\001018.mth 
Sequence File : V é04s\TCdata\NRC SSM\CANFAS Virg\001018\001018.seq 
14 16 
Time [min] 
Quantitation results 
ä^k Ret Time Delta RT Component name Area Height Amount 
M [min] [%] fjiVsec] [uVJ [mg/kgj 
BL 
1 
2 
3 
4 
S 
11.650 
12.881 
15.759 
17.867 
21.640 
24.069 
VirgMI 
—mm—~~m 
mmmm^mmm 
. . . . 
0 
44114 
46899 
38445 
52372 
56321 
0 
918 
2510 
1034 
1782 
690 
0 
0 BB 
0 BB 
0 BB 
0 BB 
0 BB 
Ol) Page lof1 
6.1.1.0.0:K20 
009 
NONE 
LC-5 
NONE 
0.00 min 
1.0000 pts/s 
1.000000 uL 
1.0000 
10/18/00 10:41:11 PM 
Software Version 
Operator 
Sample Number 
AutoSampler 
Instrument Name 
Interface Serial # 
Delay Time 
Sampling Rate 
Volume Injected 
Sample Amount 
Data Acquisition Time 
Raw Data File : W ,5o4S\TCDATA\NRC SSMVCANFAS Virg\001018\001018_016.raw 
Result File : ._ t)04s\TCdata\NRC SSM\CANFAS Virg\001018\001018_016.rst 
Inst Method : \» J004s\TCdata\nrc ssm\canfas virg\001018\001018 from V ;004s\TCdata\NRC SSM\CANFAS 
Virg\u01018\001018_016.rst 
Proc Method : \ „ . J04s\TCdata\nrc ssrmcanfas virg\001018\001018.mth 
Calib Method : V. j004s\TCdata\nrc ssmteanfas virg\001018\001018.mth 
Sequence File : \ ,f004s\TCdata\NRC SSM\CANFAS Virg\001018\001018.seq 
Date 
Sample Name 
Study 
Rack/Vial 
Channel 
A/D mV Range 
End Time 
Area Reject 
Dilution Factor 
Cycle 
: 10/19/00 10:48:09 AM 
: 21041 
: 71.311.40 
: 0/0 
: A 
: 2000 
: 30.00 min 
: 500.000000 
1.00 
16 
[iiii[im|iiii|iiii[iiii|iiii|!iiijiiii)iiii|m 
2 4 6 6 10 12 14 16 18 20 22 24 26 28 
Time [min] 
Quantitation results 
9 iak Ret Time [min] 
1 
2 
3 
4 
5 
6 
11.350 
11.650 
12.411 
13.415 
15.704 
17.859 
19.975 
Delta RT Component name 
[%] 
VirgMI 
Area 
[uVsec] 
32522 
0 
16584 
47130 
40239 
27331 
72259 
Height Amount 
[uV] [mg/kgj 
2042 
0 
1296 
3142 
1952 
804 
1118 
0 
0 
0 
0 
0 
0 
0 
BL 
BB 
BB 
BB 
BB 
BB 
BB 
f i 
Software Version 
Operator 
Sample Number 
AutoSampler 
Instrument Name 
Interface Serial # 
Delay Time 
Sampling Rate 
Volume Injected 
Sample Amount 
Data Acquisition Time 
: 6.1.1.0.0:K20 
: 010 
: NONE 
: LC-5 
: NONE 
: 0.00 min 
1.0000 pts/s 
LOOOOOOML 
1.0000 
10/18/00 11:11:57 PM 
Date 
Sample Name 
Study 
Rack/Vial 
Channel 
A/D mV Range 
End Time 
Area Reject 
Dilution Factor 
Cycle 
Fige 1 of 1 
: 10/19/00 10:48:10 AM 
: 21042 
: 71.311.40 
: 0/0 
A 
2000 
30.00 min 
500.000000 
1.00 
17 
Raw Data Hie : \U . ,.004S\TCDATA\NRC SSM\CANFAS V7rg\001018\001018 017 raw 
Result File : W. ,i)Ö4s\TCdata\NRC SSM\CANFAS Virg\001018\001018_017.rst 
Inst Method : , ,/004s\TCdata\nrc ssmteanfas virg\001018\001018 from V ";004s\TCdata\NRC SSM\PAMPAC 
Virg\001018\001018_017.rst «I»-«NI-AS> 
Proc Method : V. jÓ04s\TCdata\nrc ssm\canfas virg\001018\001018.mth Calib Method : % 4>04s\TCdata\nrc ssm\canfas virg\001018\001018.mth 
Sequence File : y /004s\TCdata\NRC SSM\CANFAS Virg\001018\001018 
.seq 
14 is 
Time fmin] 
l'iiii|iiii|ini|iiii|iiii|n 
24 26 28 
Quantitation results 
£gak Ret Time Delta RT Component name Area Height Amount BL 
W} [min] [%] [MV*sec] t"VJ [mg/kg] 
1 
2 
3 
4 
5 
6 
7 
11.646 
12.772 
13.445 
16.222 
17.872 
19.880 
21.614 
-0.0327 Virg M1 145486 6327 
133148 3753 
32422 2132 
228388 4398 
39616 1008 
83382 1358 
59304 2059 
4 BB 
0 BB 
0 BB 
0 BB 
0 BB 
0 BB 
0 BB 
Page 1 of < 
Software Version 
Operator 
Sample Number 
AutoSampler 
instrument Name 
Interface Serial # 
Delay Time 
Sampling Rate 
Volume Injected : 
Sample Amount : 
Data Acquisition Time : 
: 6.1.1.0.0:K20 
: 011 
• NONE 
LC-5 
NONE 
0.00 min 
1.0000 pts/s 
1.000000 uL 
1.0000 
10/18/00 11:42:42 PM 
Date 
Sample Name 
Study 
Rack/Vial 
Channel 
A/D mV Range 
End Time 
Area Reject 
Dilution Factor 
Cycle 
: 10/19/00 10:48:11 AM 
: 21043 
: 71.311.40 
: 0/0 
: A 
: 2000 
: 30.00 min 
500.000000 
1.00 
18 
Raw Data File : V, .'004SYTCDATA\NRC SSM\CANFAS Virg\001018\001018_018.raw 
Result File : V *004s\TCdata\NRC SSM\CANFAS Virg\001018\001018_018.rst 
Inst Method : H /.004s\TCdata\nrc ssm\canfas virg\001018\001018 from Y 004s\TCdata\NRC SSM\CANFAS 
Virg\001018\00;1018_018.rst 
Proc Method : \ yt)04s\TCdata\nrc ssrrAcanfas virg\001018\001018.mth 
Calib Method : 1 ;004s\TCdata\nrc ssm\canfas virgV001018\001018.mth 
Sequence File : ' *004s\TCdata\NRC SSM\CANFAS Virg\001018\001018.seq 
ll|HII|llll|llll{llll|llll|llll|llll|llll|llll|llll|llll|llll|llll|llll|llll|llll|IIIH^ 
2 4 6 8 10 12 14 16 18 
Time ImJn] 
Quantitation results 
20 
ÏÏÏÏ1 
22 24 26 
rTTTTTTTTT] 
28 
Peak 
1 
2 
3 
4 
5 
6 
7 
Ret Time 
fmin] 
10.356 
11.359 
11.650 
12.414 
13.419 
15.719 
17.874 
19.927 
Delta RT Component name 
ro/.i 
VirgMI 
Area 
fjjV*sec] 
33050 
42356 
0 
17120 
75800 
31060 
26658 
85882 
Height Amount 
fuV] [mg/kg] 
1995 
2561 
0 
1335 
4925 
1770 
772 
1305 
0 
0 
0 
0 
0 
0 
0 
0 
BL 
BB 
BB 
BB 
BB 
BB 
BB 
BB 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 32 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . j 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGINIA^YCIN 
Unit 
Sample code 
326839 
326880 
326881 
326916 
326923 
326928 
326936 
326952 
Result 1 
(mg/kg) 
0/I1 
0,16 
0,19 
Negative 
0,12 
Negative 
Negative 
Negative 
Result 2 
(mg/kg) 
0,1 
0,51 
0,55 
Negative 
0,12 
Negative 
Negative 
Negative 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Calculation «* *»« «*<** cnliition f4.4.1): 
. Amount of virginiamycin reference standard weighed: 10 mg 
• Volume of methanol: 39.5 ml 
. Concentration of the stock solution: 550 »g microbiological activity/ml 
Chromatoaraphifi «éditions: 
• Column: 
• a As described in the method 
. w i ther Waters Symmetry, C18, 5 um, 4.6mmX250mm (Part N° WAT 054215) 
• Mobile phase: 
. XAs described in the method 
• D Other 
• FIcAAKate: 1.0 ml/min 
• Injection volume: 100 (^L) 
. Retention time of virginiamycin M1 :9.50 min 
r h r ^ t ^ r a m s - P — '™»»dc representative chromatoqrams of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the virginiamycin M1 peak with an arrow 
Rar/werv results; 
• Percentage recovery: 42.5 % 
. Single/duplicate determinations: • single D duplicate 
. If duplicate, p l -se give both percentages: 41.74% and 43.35% 
• Spiking level: 4 mg/kg 
Page 1 of 1 
Data F i l e C:\HPCHEH\1\DATA\21122000\VIRGIN05.D 
4ppm, massa-5.00g. 
Sample Name: C2 
I n j e c t i o n Date 
Sample Name 
Acq . O p e r a t o r 
Acq . Method 
L a s t changed 
: 1 2 / 2 1 / 0 0 5 : 2 9 : 4 2 PH S e q . L i n e : 5 
: C2 V i a l : 8 
: I n j : 1 
I n j Volume : 100 u l 
: C:\HPCHEH\l\HETHODS\VIRGINIA.H 
: 1 2 / 2 1 / 0 0 5 : 2 7 : 0 8 PH b y 
Analysis Hethod 
Last changed 
(modified after loading) 
C:\HPCHEHN 1\HETHODS\VIRGINIA.H 
12/22/00 9:42:4? AH by , 
(modified after loading) 
• Symmetry, 250 x 4 
DAD1 A, Sig=235.4 R«t=3e0.4<21122000WlRGIN05.D) 
mAU-
1600-
1400-
1200-
1000-
800-
600 
400-
200-
< 
5 
I ( 
S § ? 8 / 
3 
D 
1 Pi 
1 
TV Ml J 
\ 
\ S 
1 2 4 -ß 
6 mm, r e f . ÜAT054215,Waters. 
8 8 3 g 
.ci K r^  <D 
i 
8 
Irt/lKwtjMUJttJ 
« 
g 8 * S 
m 
External Standard Report 
S o r t e d By 
C a l i b . Data H o d i f i e d 
H u l t i p l i e r 
D i l u t i o n 
S i g n a l 
F r i d a y , December 2 2 , 2 0 0 0 9 : 3 8 : 3 7 AH 
1 . 0 0 0 0 
1 . 0 0 0 0 
S i g n a l 1: DAD1 A, S i g - 2 3 5 , 4 R e f - 3 6 0 , 4 
RetTime Type H e i g h t Amt /He ight Amount Grp Name 
[min] [mAU] [ u g / m l ] 
• I - • I - •I • I - - I — ! • 
9 . 4 5 9 W 1 0 . 1 5 3 2 4 1 . 7 0 7 7 0 e - l 1 . 7 3 3 8 7 
T o t a l s : 1 . 7 3 3 8 7 
R e s u l t s o b t a i n e d w i t h e n h a n c e d i n t e g r a t o r ! 
I n s t r u m e n t 1 1 2 / 2 2 / 0 0 9 : 4 2 : 4 9 AH 
V i r g i n i a m y c i n 
Page 1 o f 
file://A:\Vir2.gif 09-01-2001 
ata F i l e C:\HPCHEH\1\DATA\21122000\VIRGIN10.D 
i 
Code 32 6839 , massa - 5 . 0 0 2 8 g 
Sample Name: 326839 
I n j e c t i o n Date 
Sample Name 
Acq. Operator 
Acq. Kethod 
L a s t changed 
A n a l y s i s Method 
Las t changed 
1 2 / 2 1 / 0 0 6 : 4 7 : 5 8 PH 
326839 
<® 
C:\HPCHEH\1\KETH0DS\ VIRGINIA. H 
1 2 / 2 1 / 0 0 6 : 4 5 : 2 5 PH by 
( m o d i f i e d a f t e r l o a d i n g ) 
C:\HPCHEH\1\HETH0DS\VIRGINIA.H 
1 2 / 2 2 / 0 0 9 : 4 4 : 4 2 AH b y 
( m o d i f i e d a f t e r l o a d i n g ) 
Seq . L i n e : 10 
V i a l : 10 
I n j : 1 
I n j Volume : 100 u l 
mAU 
1200 4 
. - Symmetry, 250 x 4 . 6 mm, r g f . STAT054215 H»t-.r.. 
DAD1 A. Siö=235.4 Rs*=3OT.4pi1Z2000WIRÖlNÏo3j "" waluJH£- 1 3 r w a t e r y 
1000 
600 
600 
400 
200 
* n i 
o o 
— 4 1 _ 
E x t e r n a l S tandard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
Friday, December 22, 2000 9:38:37 AH 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig-235,4 Ref-3 60,4 
RecTime Type Height Amt/Height Amount Grp Name 
twin] [mAU] [ug/ml] 
•I •I-1 1 
9.451 W 2.81636 1.58496e-l 4.46382e-l 
Totals : 4.46382e-l 
Results obtained with enhanced integrator ! 
tfUMent 1 12/22/00 9:44:43 AH 
•I — I 
Virginiamycin 
Page 1 of 2 
Page 1 of 1 
@ > 
Data F i l e C:\HPCHEH\1\DATA\21122000\VIRGIN15.D 
Code 32 688C, m a s s a - 5 . 0 0 3 2 g 
Sample Name: 32 6 8 8 0 / 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Hethod 
Last changed 
: 12/21/00 8:06:12 PH Seq. Line : 15 
: 326880/ Vial : 14 
: r Inj : 1 
Inj Volume : 100 ul 
: C:\HPCHEH\1\HETHODSN VIRGINIA.H 
: 12/21/00 8:03:36 PH by f 
A n a l y s i s He thod 
L a s t c h a n g e d 
( m o d i f i e d a f t e r l o a d i n g ) 
C:\HPCHEH\1\HETH0DSWIRGIKIA.H 
1 2 / 2 2 / 0 0 9 : 4 6 : 2 8 AH b y 
( m o d i f i e d a f t e r l o a d i n g ) 
DAD1 
mAU 
1750H 
1500 
1250-
1000 
750 
500 
250 
.f Symmetry, 2 5 0 x 4 . 6 mm, r é f . P A T 0 5 4 2 1 5 , P a t e r s . 
A. Sig=235.4 Ref=360.4(21122000\VIR6IH15.D) 
8 8 M I 
\fMKfYv\0iu|aN 
1 
T -
O ê § 
4ï-
-j— 
External Standard Report 
Sorted By 
Calib. Data Hodified 
Hultiplier 
Dilution 
Signal 
Friday, December 22, 2000 9:38:37 AH 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig-235,4 Ref-360,4 
RetTime Type Height Amt/Height Amount Grp Name 
[min] [mAU] [ug/ml] 
• ! • • ! • • ! • -I—I 
9 . 4 7 5 VP 1 4 . 8 2 1 7 6 1 . 7 2 2 5 4 e - l 2 . 5 5 3 1 1 
T o t a l s : 2 . 5 5 3 1 1 
R e s u l t s o b t a i n e d u i t h e n h a n c e d i n t e g r a t o r ! 
I n s t r u m e n t 1 1 2 / 2 2 / 0 0 9 : 4 6 : 3 0 AH 
V i r g i n i a m y c i n 
Page 1 o f 
file://A:\Vir9.gif 11-01-2001 
Page 1 of 1 
® 
Data Tile C:\HPCHEH\1\DATA\21122000\VIRGIN22.D 
Code 32 6916, massa - 5.00038g 
Sample Name: 326916/ 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Betbod 
Last changed 
Analysis Hethod 
Last changed 
12/21/00 9:56:07 PH 
326916/ 
C:\HPCHEHN1\HETH0DS\VIRGINIA.H 
12/21/00 9:53:33 PH by . 
(modified after loading) 
C: A HPCHEH\1\HETHODS\VIRGINIA.H 
12/22/00 10:11:41 AH by < 
(modified after loading) 
Seq. Line 
Vial 
Inj 
Inj Volume 
22 
20 
1 
100 ul 
. Symmetry, 250 x 4.6 mm, réf. PAT054215,Paters! 
DAD1 A. Sig-235.4 Re*=380.4C21122000\VIROIN22.D) 
External Standard Report 
Sorted By 
Calib. Data Hodified 
Huitiplier 
Dilution 
Signal 
rriday, December 22, 2000 9:3B:37 AH 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig-235,4 Ref-360,4 
RetTime Type Height Amt/Height Amount Grp Name 
[min] [MA°] [ug/ml] 
•I- • ! • 
"V~A19VV l. 34690 ' 1.399656-1 l.BB51Be-l 
„, ^ , 1.8851Be-l 
Totals : 
Results obtained with enhanced integrator! 
Instrument 1 12/22/00 10:11:42 AH , 
Virginiaraycin 
Page 1 of 
file://A:\Virl5.gif 09-01-2001 
D a t a F i l e C:\HPCHEH\l\DATA\21122000WIRGIN2e.D 
Code 32 6 9 2 8 , m a s s a - 5 . 0 0 2 0 g 
Page 1 of 1 
Sample Name: 32 6928 
© 
I n j e c t i o n Date 
Sample Name 
Acq. O p e r a t o r 
Acq. Hethod 
L a s t c h a n g e d 
: 1 2 / 2 1 / 0 0 1 1 : 3 0 : 0 8 PH S e q . L i n e : 
: 32 6928 V i a l : 
:
 / I n j : 
I n j Volume : 
: C:\HPCHEH\i\HETHODS\VIRGINIA.H 
: 1 2 / 2 1 / 0 0 1 1 : 2 7 : 4 1 PH b y 
28 
25 
1 
loo m 
Analysis Hethod 
Last changed 
(modified after loading) 
C:\HPCHEHN1\HETH0DS\VIRGINIA.H 
12/22/00 10:15:05 AH by -" 
(modified after loading) 
Symmetry , 2 5 0 x 4 . 
DAD1 A. Sig=235.4R*f=360.4(21122000\VIRGIH28.D) 
mAU 
1600-
1400-
1200-
1000-
800-
600-
<wo-
200-
o-
« 
S 
i ( 
B6 8 9 * J 
d o D •- *" . ~f 
D 
si 
VI.i — 1 _ » 
6 mm, r é f . V A T 0 5 4 2 1 5 , B a t e r s . 
0.
70
2 
8.
04
) 
0.
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External Standard Report 
Sorted By 
Calib. Data Hodified 
Huitiplier 
Dilution 
Signal 
Triday, December 22, 2000 9:38:37 AH 
1.0000 
1.0000 
S i g n a l 1 : DAD1 A, S i g - 2 3 5 , 4 R e f - 3 6 0 , 4 
RetTirae Type 
[min] 
H e i g h t A m t / H e i g h t Amount 
[mAü] [ u g / m l ] 
Grp Name 
•I •I- • ! • •I—I 
9.180 VP 7.55841e-l 1.12191e-l 8.47986e-2 
Totals : B.47986e-2 
Results obtained with enhanced integrator! 
Instrument 1 12/22/00 10:15:06 AH 
Virginiamycin 
P«g» 1 of 
file://A:\Vir20.gif 11-01-2001 
Data F i l e C:\HPCHEH\1\DATA\21122000WIRGIN31.D 
Code 32 693 6, m a s s a - 5 . 0 0 2 6g 
Page J of 1 
Sample Name: 32 693 6 
I n j e c t i o n Date 
Sample Name 
Acq. Operator 
Acq. Hethod 
L a s t changed 
: 1 2 / 2 2 / 0 0 1 2 : 1 7 : 0 0 AH S e q . L i n e : 
: 32 693 6 V i a l : 
: • I n j : 
I n j Volume : 
: C:\HPCHEH\1\HETH0DS\VIRGINIA.H 
: 1 2 / 2 2 / 0 0 1 2 : 1 4 : 3 2 AH b y - . 
31 
28 
1 
100 u l 
( m o d i f i e d a f t e r l o a d i n g ) 
A n a l y s i s Hethod : C:\HPCHEH\l\HETHODS\VIRGINIA.H 
L a s t changed : 1 2 / 2 2 / 0 0 1 0 : 1 6 : 4 4 AH b y . 
( m o d i f i e d a f t e r l o a d i n g ) 
_. ~ __, Symmetry, 250 x 4 . 6 am, r e f . PAT054215. Pater-«. 
DAD1 A. Sig=235.4 Rtf»380.4pi122000WIR©IN31.D) 
s § s e 
< — I —I I 
— J -
_IQ_ 
External Standard Report 
Sorted By 
Calib. Data Hodified 
Hultiplier 
Dilution 
Signal 
Friday, December 22, 2000 9:38:3? AH 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig-235,4 Ref-360,4 
RetTime Type Height Amt/Height Amount Grp Name 
[min] [">A°]_ ! , J_^tL., __, 
-I- •I 4.34815 1.64480e-l 7.15184e-l 
7.151B4e-l 
9.272 W 
Totals : 
Results obtained with enhanced integrator 
Instrument 1 12/22/00 10:16:45 AH . 
Virginiamycin 
Page 1 of 
file://A:\Vir23.gif 1141-2001 
î t a F i l e C:\HPCHEH\1\DATA\21122000\VIRGIN36.D 
Code 32 6 9 5 2 , massa - 5 . 0 0 0 3 g 
Sample Name: 32 6 9 5 2 / 
@ 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Last changed 
Analysis Hethod 
Last changed 
12/22/00 1:35:19 ÀH 
326952/ 
Seq. Line 
Vial 
Inj 
Inj Volume 
36 
32 
1 
100 ul 
C: S HPCHEH\1\KETH0DS\VIRGINIA.H 
12/22/00 1:32:48 AH by " 
(modified after loading} 
C:\HPCHEH\1\HETH0DS\VIRGINIA.E 
12/22/00 10:18:51 AH by 
(modified after loading) 
, Symmetr-p, 250 x 4.6 mm, ref. PAT054215/¥aters. 
DAD1 A, Sig=235.4Re^=380.4C21122000WIRGIN36.D) 
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External Standard Report 
Sorted By 
Calib. Data Hodified 
Multiplier 
Dilution 
Signal 
Friday, December 22, 2000 9:38:37 AH 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=235,4 Ref-360,4 
RetTime Type 
[min] 
1 
•I 
Height Amt/Height Amount 
[mAU] [ug/al] 
1 1 
Grp Name 
•I--I 
9.266 VP 4.34639 1.64475e-l 7.14873e-l 
Totals : 7.14873e-l 
Results obtained with enhanced integrator ! 
trument 1 12/22/00 10:18:52 AH 
Virginiamyc in 
Page 1 of 2 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 37 
Annex 2 
CANFAS 
; Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
. - • . . . . . . • • • . • - . . . . . . . . • . . - . - _ . - . . j 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
VIRGIN lÄWfYCM 
Unit 
Sample code 
376835 
376836 
376844 
376854 
376868 
376895 
376906 
376917 
Result 1 
(mg/kg) 
ND 
Lost Sample 
8,04 
7,99 
7,88 
2,28 
ND 
ND 
Result 2 
(mg/kg) 
ND 
ND 
6,05 
7,26 
Lost Sample 
2,42 
ND 
ND 
08/12 '00 10:20 @008 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Anne« 4 - Questionnaire 
n^rf«**Jtf^»£JM«S 
nidations f r t f r «*"* snhitinn f4.4.1); 
• Amount of virginiarnycin reference standard weighed: ..1.1 mg 
• Volume of methanol: 3§:.§?..... ml 
. Concentration of the stock solution: .<&*?... ug microbiological activHy/ml 
QlP)nyifnprnphJr r"""^"""s: 
• Column: ." 
. Q/fo described in the method i l y f f « * «fes o * «aS«~ * <*-t mm , Sy^ 
m D Other 
- Mobile phase: 
• r**is described "m the method 
• o Other: • 
. Flowrate: J « M " * 
m Injection volume: .IRfi....4Jl 
. Retention time of wirgWamydn Ml: ~*»» n*i 
r t i n r T T a t n g r a m r Plf»a«B încll ldp renresentative ghromatograms oft 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virgmiamyckiMl peak with an arrow 
Recovery résulte; 
• PercBriUdge rwuuery: .HP.. * , 
. Single/duplicatedeterminations: Dsingle tB^upfcate 
. If duplicate, please give both percentages: i&. % and St. % 
- Spiking level: . . I f mgAfi 
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APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 38 
Annex 2 
CANFAS 
! Development and Validation of HPLC-methods for the official control of 
jÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Analyte: VIRGiNfAMYCIM 
Unit 
Sample code 
386860 
386862 
386864 
386865 
386905 
386924 
386947 
386948 
Result 1 
(mg/kg) 
0,52 
0 
1,45 
0 
0 
0 
0,79 
0 
Result 2 
(mg/kg) 
0,54 
0 
1,61 
0 
0 
0 
0,78 
0 
CANFAS COLLABORATIVE STUDIES - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Date(s) of analysis: 12/05/00 
Calculation for thp stock solution (4.4.1): 
• Amount of virginiamycin reference Standard weighed: 10.0 mg 
• Volume of methanol: 100 ml 
• Cocentration of the stock solution: 225 ug/ml microbiological activity 
Chromatographie conditions: 
• Column: 
O As described in the method 
X Other: Hypersil ODS C-18, 250 x 4,6 mm, 5 urn 
• Mobile phase: 
O As described in the method 
X Other Water/Acetonitrile/Acetic Acid (650:350:3) 
• Flow-rate: 1 ml/min 
• Injection volume: 20 pi 
• Retention time of virginiamycin M1: 18 min 
Chromatograms: Please include representative chromatoarams of: 
• Blind positive feed samples 
• Blind blank samples 
Please indicate the virginiamycin M1 peak with an arrow 
Recovery results: 
• Percentage recovery: ... % 
• Single / duplicate determinations: G single X duplicate 
• If duplicate, pleats give both percentages: 60 % and 93 % 
• Speaking level: 4,5 mg/kg fm.a.) 
CANFAS COLLABORATIVE STUDIES - VIRGINIAMYCIN 
Remarks / Comments (if necessary, continue on another page): 
Please note that samples labeled as 386860 and 386947 has been quantified around our Limit of 
Determination. (LD = 0,6 mg/Kg) 
Chromatograms for standard (45 ppm m.a.), sample (386864) and blank 
DAD1 A, Sig=235,4 Ref=500,80 (LSPA\VIRGIN~1\ ' ^1\VGMN3004.D) 
mAin 
25 Ï 
20 
15-i 
10-Ê 
5-Î 
0 
CO o o 
Virginiamycin *-
DAD1 A, Sig=235,4 Ref=500,80 (LSPA\VIRGIN~1\r' -1WGMN3013.D) 
- r -—r——-r—— i— - I ' 'T" I I 
10 15 
DAD1 A, Sig=235,4 Ref=500,80 (LSPA\VIRGIN~H mm -1WGWN3015.D) 
Appendix 7 
Results of special requests: 
LC-MS/MS results 
Departement voor Kwaliteit van Dierlijke Producten (DVK-CLO), Melle, Belgium 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - VIRGINIAMYCIN 
Annex 4 - Questionnaire 
Laboratory: D.V.K.^.X.LO. 
Contact person: H.:..D.E....R..VIYCK. 
Date(s) of analysis: ....2D..~&!3rl41.l.0.Q.. 
Calculations for the stock solution (4.4.1): 
• Amount of virginiamycin reference standard weighed: ....<&#... mg 
• Volume of methanol: hiW.... ml 
• Concentration of the stock solution: ...5.Û.Q. ug microbiological activity/ml 
Chromatographic conditions: 
• Column: 
D As described in the method • D As described m the method s a/>i D\ 
. 0 Other: ...flAfctók*...£*.Ï 5jfi*. d^.KM.fJ^Xt CME^J 
• Mobile phase: 
• ß As described in the method 
• pother: 
• Fiovwate: ....Qt.aL5. ml/min 
• Injection volume: ....5-—M' 
• Retention time of virginiamycin Ml : .©ÂQ min 
Chromato^rams: Please include representative chromatoprams of: 
• Blind positive feed samples 
• Blind blank feed samples 
Please indicate the virginiamycin Ml peak with an arrow 
Rernverv results: 
• Percentage recovery: % 
• Single / duplicate determinations: G single K duplicate 
• If duplicate, please give both percentages: 84-5% and Ql:lr% 
• Spiking level: \ri- mgAg 
Tuning Method Report 
Method : C : \MASSLYNX\ACQUDB\MSMS 
Printed: Thu Dec 07 16:41:37 2000 
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SOURCE < ESP+ ) 
Capillary 
Cone 
Extractor 
RF Lens 
Source Block Temp. 
Desolvation Temp. 
Sat Rdbk ' Analyser 
3.50 
2 
0.50 
130 ** 
250 2* 
0.02 
-3 
-1 
Pressures 
Analyser Vacuum 
Gas Cell 
Rdbk 
5.0e-6 
2.0e-5 
LM Res 1 
HM Res 1 
IEnergy 1 
Entrance 
Collision 
Exit 
LM Res 2 
HM Res 2 
IEnergy 2 
Multiplier 
Gas Flows 
Nebuliser 
Drying 
S a t Rdbk 
1 1 . 0 
1 1 . 0 
1 .5 
6 , - 0 
•8*4-0 - 1 
6 - 0 
1 1 . 0 
1 1 . 0 
2 . 0 
643 4 
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